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Abstract

The exact nature of the mechanisms and the regulation of vascular smooth muscle

contraction is not well understood. To better understand these processes, we examined

two systems involved in smooth muscle contraction, the cytoskeleton and the protein

kinases. In order to study the role of the cytoskeleton in smooth muscle contraction, we
examined the contractile and mechanical effects of cytoskeletal disruption. We found
that the relationship between passive tension applied to aortic rings and the resulting
increase in tissue length was nearly linear over the range of 1 g to 15 g. However, even
with increasing tissue length, within the range of 1 g to 10 g passive tension, the total

active force generated upon stimulation was not significantly changed. These

obsei-vations emphasize the great flexibility of the mechanism(s) underlying the
contractile response of vascular smooth muscle with regard to changes in tissue preload
and length. Neither the blockade of microtubule polymerization by colchicine nor actin

polymerization by cytochalasin B significantly changed the slope of the tissue length
passive tension preload curve indicating no effect on the tissues' capacity to stretch at a

given preload. With stimulation of the tissue at different levels of stretch, colchicine
caused an increase in the initial fast component of active tension development, but

partially blocked the secondary slow rise in tension. Cytochalasin B dramatically reduced
the total contractile response at each preload studied, and this effect was confined almost

exclusively to the secondary slow increase in tension. When tissues were cooled to cause

complete dissolution of the microtubule network and then warmed in the presence of

iv

colchicine to prevent repolymerization of both the active and stable populations of
microtubules, there was also a significant reduction in the slow component of contraction

with no effect on the fast response. The partial blockade of synthesis of the microtubuleassociated motor protein kinesin by application of an antisense oligonucleotide to aortae

in situ or to aortic rings in tissue culture significantly reduced the contractile response to
potassium depolarization. These results suggest that the microtubules and the actin

filaments of the cytoskeleton play an active role in slow force development as opposed to
a solely passive role based on the effect of the static, structural properties of these

filaments on mechanical resistance. We propose that a tension-bearing element of the

actin-containing cytoskeleton undergoes remodeling to adjust tension within the system.
The microtubules could act through either the direct action of kinesin-mediated
intracytoskeletal interactions in force development that involve a remodeling of the

tension-bearing elements of the cytoskeleton or through the directed movement of the

molecules involved in the transduction process.

Because the cytoskeleton and the protein kinases of smooth muscle are intimately linked,

we examined the potential role of protein kinases in vascular smooth muscle contraction.
We began by assessing the effects of a panel of specific kinase inhibitors on smooth

muscle contraction. We found reductions in contraction with inhibition of myosin light
chain kinase (MLCK), calcium-dependent calmodulin kinase (CaMKII), mitogen

activated protein (MAP) kinase, and protein kinase C (PKC). Protein kinase C (PKC) is
v

translocated in an isofbrm-specific manner to distinct subcellular locations after

stimulation of cells. It is thought that translocation is essential fbr PKC activation and
that cellular localization underlies the PKC isofbrm-specific phosphorylation of substrate
in the intact cell that is largely absent in in vitro assays. In the present studies, it was
shown using Western blot analysis that the ratio of particulate to cytosolic PKC-a was

reduced in rat aortic segments treated with colchicine to disrupt microtubular structure
prior to stimulation with phorbol 12, 13 dibutyrate (PDB). Subsequent studies using laser

confocal microscopy revealed that within thirty seconds after stimulation with PDB,
PKC-a in cultured rat aortic smooth muscle cells changed from a diffuse cytoplasmic

distribution to a highly structured filamentous pattern of staining. Dual immunostaining
further indicated that the stimulation-induced filamentous pattern was due to co
localization of PKC-a with cell microtubules. At longer time intervals after PDB

stimulation, PKC-a was observed to translocate to the perinuclear region of the cell.
Disruption of the microtubular but not the actin-containing component of the

cytoskeleton blocked the translocation of PKC-a to the perinuclear membrane. It was
further shown that slow tension development, which has been reported to be selectively

blocked by PKC antagonists in vascular smooth muscle, was also blocked by disruption

of the cell microtubules. The results provide further evidence fbr the involvement of

PKC in slow tension development by smooth muscle and indicate that PKC translocation

may involve microtubular transport.
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Literature Review

Smooth muscle was named due to its appearance when observed under early light

microscopes. The nature of the smooth muscle cell was one of a homogenous base
substance contained within a fusiform cell with a centrally placed nucleus. Upon further

exploration, smooth muscle was found to be present in the cylindrical or hollow organs of
six different systems: gastrointestinal, ocular, reproductive, respiratory, urinary and

vascular. In each of these instances, with the exception of the ciliary muscle of the eye,
the function of the smooth muscle is storage and transport, and because of this, smooth
muscle is often considered a tissue of conductance and capacitance. This is not to say,
however, that smooth muscle is an inert tissue, serving only as a conduit for various

fluids. Within the gastrointestinal system, the smooth muscle of the stomach and
intestines provides the motile force behind the directed movements of digestion. This

function is mirrored in the reproductive and urinary systems. It is perhaps within the
cardiovascular system, however, that the active nature of smooth muscle may best be
observed. While the pumping of the heart is responsible for the propulsion of blood

through the vasculature, it is the resting tone of the vessels that is the major determinant
of the fluid dynamics of the system. This high degree of regulation within the
cardiovascular system, as well as the functions carried out by the smooth muscle of other

systems, is all due to the excitable nature of smooth muscle. In other words, smooth
muscle has the ability to contract.

1

Following the discovery that smooth muscle could contract, the next questions were: in
response to what, and by what mechanism. A convenient answer to the latter question

was provided by data collected from skeletal muscle. Skeletal muscle, which falls under
the classification of striated muscle, is characterized by its ordered arrangement of

regularly spaced sarcomeres that move closer together upon contractile stimulation.
Further investigation revealed the sarcomeres to be comprised of interdigitating filaments

of actin and myosin. This finding was the basis fbr the sliding filament theory of muscle
contraction first proposed by A.F. Huxley in 1957 and further elaborated on by H.E.

Huxley in 1969. The basic principles of sliding filament theory are that the initial

increases in intracellular calcium, found upon muscle stimulation, causes calcium to bind

to troponin. This binding causes a shift of tropomyosin out of its resting position in the

grooves within the actin helices, and this, in turn, causes a disinhibition of the interaction
of actin and myosin. When inhibition is lifted, the binding of actin and myosin activates
the ATPase in the myosin head, and stable crossbridges between the filaments are

formed. Following this, the hydrolysis of ATP and the conformational change of myosin
induced by hydrolysis provide the force necessary to pull the actin and myosin past each

other. This repeats countless times in a ratcheting fashion. These biochemical events

combined with the opposing interdigitation of the actin and myosin produce a shortening
of each individual contractile unit, or sarcomere. In addition, because the sarcomeres are
arranged in register, and because of the fixed nature of the muscle attachments, the

simultaneous actin:myosin interactions in the sarcomeres produce a net shortening, or

contraction, of the muscle as a whole.
2

Despite the presence of gross morphological differences between smooth and striated

muscle, much of the initial work concerning the biochemistry and biophysics of smooth

muscle contraction was analyzed and presented within the existing parameters that had
been determined for striated muscle contraction. This basic framework became accepted

as a viable model for the mechanisms of muscle contraction, regardless of cell type
(Marston and Smith, 1985).

Contradictions to Convention in Smooth Muscle

It is widely held that the principal

biochemical and biophysical events underlying the contraction of smooth muscle are

similar to those of skeletal and cardiac muscle. Stimulation of smooth muscle results in
an elevation in intracellular calcium which binds to calmodulin. The calcium-calmodulin

complex then activates myosin light chain kinase (MLCK) with a resulting

phosphorylation of the Seri 9 residue on the myosin light chains. This phosphorylation
allows for activation of the myosin ATPase, cycling of myosin crossbridges along the

actin filament, and the subsequent development of force. While there are these
similarities in the initiation of contraction, there are a number of observations that bring
the direct applicability of the sliding filament model to smooth muscle into question.

Smooth muscle is capable of generating at least as much tension as striated muscle
(Murphy, 1976). In striated muscle, the active force developed is in direct proportion to
the degree of overlap of the actin and myosin filaments (Gordon et al., 1966). In smooth

muscle, however, the association of myosin with actin filaments appears to be less well
organized (Rice et al., 1970; Somlyo, 1980). Where a clear actin-myosin relationship is

3

observed, the actin filaments are arranged in bundles or rosettes of up to 15 filaments to

each myosin. Moreover, the myosin content of smooth muscle may be as little as 20% of
that of striated muscle (Murphy et al., 1974; Murphy, 1976). Given the arrangement of

the myofilaments and the low contractile protein content, it is difficult to envision the

mechanical or biochemical advantage which allows for the level of force developed by
smooth muscle operating with only a sliding filament-based mechanism.

Smooth muscle has the unique ability to slowly develop force, and to then maintain this

tension for extended periods (Figure 1). Furthermore, this maintenance of force occurs at
levels of energy consumption which are about 0.35% of those seen in striated muscle

(Paul, 1983). There is evidence to indicate that the slow force development and
maintained tension (Driska et al., 1981) and velocity of shortening (Merkel et al., 1990)
are dissociated from myosin light chain phosphorylation and actin-activated myosin

ATPase activity (Zhang and Moreland, 1994) in smooth muscle. Most interestingly, it

has been demonstrated that the phorbol ester- induced contraction of smooth muscle can
occur in the absence of an increase in intracellular Ca2+ (Nakajima et al., 1993) or

concomitant myosin light chain phosphorylation (Singer and Baker, 1987). Hence, there

is a need to understand the differences in the biochemical mechanisms between striated
and smooth muscle contraction.

4
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Figure 1
Graphic representation of the time course of tension development in
smooth and striated muscles in response to a single activating stimulus. Smooth muscle
is characterized by a rapid increase in tension followed by a slow generation of tension
and maintenance of developed force. Striated muscle also rapidly develops active
tension, but contraction quickly returns to baseline, with no maintenance of developed
force.
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Compensation for Low Myosin Levels in Smooth Muscle

The myosin of smooth

muscle is myosin II, similar to the myosin of striated muscle. Myosin II has two heavy
chains with globular heads and a-helical tails. Covalently bound to the tails of the heavy
chains are two types of light chains, the essential (ELC) and the regulatory (RLC) light

chains. The globular heads of the heavy chains are mainly responsible fbr the work of
filament sliding as they contain both the actin binding sequence and the ATPase activity.

In vertebrate striated muscle, the light chains appear to have little impact on contraction
as removal of both classes of light chains had no effect on ATPase activity (Wagner and

Giniger, 1981). It has been speculated that, in striated muscle, the pui-pose of the light
chains is to stabilize the myosin molecule (Sivaramakrishnan and Burke, 1982). In
contrast, smooth muscle light chains, in particular the regulatory light chain, play a large

role in contraction. Phosphorylation of Serl9 in the N-terminal end of the RLC is the
essential switch that activates ATPase activity (Lowey and Trybus, 1995) and allows fbr

actin binding and subsequent force generation. Even with these differences, the same
basic mechanism of contraction is assumed to be at work. However, with such a low

density of myosin, alternative theories were needed to explain the strong contractions
developed by smooth muscle.

Many of the possible explanations offered to this problem have centered on the
mechanical properties of the myosin molecule itself. Recent work has indicated that

smooth muscle myosin translocates actin filaments at velocities as much as ten-fold

slower than does striated muscle myosin (Lowey and Trybus, 1995). This could possibly
6

explain the generation of a slowly developing contraction. However, even with the wide

range of velocities reported for smooth muscle myosins (Umemoto and Sellers, 1990;
Warshaw et al., 1990; Trybus et al., 1994; Kelley et al., 1993), it cannot explain the

rapidly developing fast component of the contraction which develops force with a
velocity comparable to that of striated muscle, nor can it explain the high level of force

generated by smooth muscle fibers.

Another possibility is that smooth muscle myosin may compensate fbr low density by

increasing the force generated by each actimmyosin crossbridge. This could be achieved
by an increase in the "duty cycle" — defined as the fraction of time that myosin remains

attached to the actin filament during the hydrolysis cycle of ATP (Uyeda et al., 1990) - or

an increase in the unitary force generated by smooth muscle myosin. Initial studies by

Harris and Warshaw (1993) found that there were no differences between the duty cycles
of smooth and skeletal muscle myosins; however, these studies were performed under
"no-load" conditions. Under loaded conditions, smooth muscle myosin was found to be

capable of generating crossbridge forces of three to four times those produced by skeletal
muscle myosin (VanBuren et al., 1994; VanBuren et al., 1995). However, it is uncertain

whether this is due to an increase in smooth muscle myosin duty cycle, increases in
unitary force, or a combination of the two (Sellers, 1996).

A final possibility hinges upon differences in the packing of myosin monomers into

filaments and the geometric arrangement of these filaments. While skeletal muscle
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myosin monomers form bipolar filaments with a characteristic central bare zone, smooth

muscle myosin aggregates into filaments in a "side-polar" orientation, leaving either end

of the filament bare of myosin heads (Craig and Megerman, 1977; Cooke et al., 1989). In

addition to this unique orientation of myosin monomers within the filament, the thick
filaments of smooth muscle are also relatively longer than those of skeletal muscle
(Ashton et al., 1975). These features would allow a large number of crossbridge
interactions per myosin thick filament, thus increasing the force capable of being

sustained by the filament (Hellstrand and Nordstrom, 1993).

Explanations for Low-Calcium Contraction

Early work with permeabilized smooth

muscle fibers, tissues in which the cellular membranes are "skinned" away from the cell
thus allowing precise control of intracellular conditions, first indicated a dependence on

calcium for contraction (Filo et aL, 1965). However, this relationship has since been
proven to not be correlative. For example, different agonists can produce similar degrees

of force development with calcium levels held at different levels. Conversely, different
agonists induce different degrees of force with equivalent changes in intracellular calcium

(Kamm and Grange, 1996). In addition, contractions elicited by activation of protein
kinase C may occur in the absence of a rise in intracellular calcium levels (Nakajima et

al., 1993). These findings have given rise to a number of theories regarding the calcium
sensitivity of smooth muscle contraction and the regulation of this property.

The calcium sensitivity of smooth muscle, defined as the degree of contractile activation

8

elicited in response to a given concentration of intracellular calcium, can be either upregulated or down-regulated. Activation of myosin light chain kinase is accomplished by

association with the calcium-calmodulin complex (Ca:CaM). If, however, the myosin
light chain kinase is itself phosphorylated, the sensitivity of the kinase to activation by

Ca:CaM is decreased, thus requiring higher levels of intracellular calcium to achieve
contraction (Conti and Adelstein, 1981). This phosphorylation occurs near the Ca:CaM

binding site (Tansey et al., 1994), and can be accomplished in vitro by protein kinase C or

by calcium-calmodulin dependent protein kinase II (CaMK II) (Kamm and Grange,
1996). However, in intact tissues, activation of protein kinase C has little to no effect on

the phosphorylation of myosin light chain kinase, suggesting that in vivo, it is CaMK II

that is responsible fbr desensitization to calcium (Stull et al., 1990; Van Riper et al.,
1995). While an understanding of this system may help to explain differences in degree

of contraction at equal levels of intracellular calcium, it does not explain how smooth
muscle can contract with low or no rises in intracellular calcium levels. An explanation
fbr this comes from work done with myosin light chain phosphatase.

Very little is known about the action and regulation of myosin light chain phosphatase

(MLCP); however, recent work suggests that activation of MLCP allows equal degrees of
smooth muscle contraction at lesser levels of intracellular calcium (Kamm and Grange,

1996). In smooth muscle, the amount of calcium necessary fbr half maximal myosin light
chain activation is much higher for tissues depolarized with potassium than for tissues

stimulated with agonists (Rembold and Murphy, 1988; Karaki et al., 1989; Tang et al.,
9

1992). This effect can also be elicited by the application of GTP to the preparation
(Nishimura et al., 1988; Kitazawa et al., 1989), and this GTP effect is associated with

increased phosphorylation of myosin light chain (Kubota et al., 1992). It appears that this
increase in phosphorylation is not due to a potentiation of myosin light chain kinase
activity by the GTP, but rather to an inhibition of myosin light chain phosphatase activity

(Kitazawa et al., 1991). It is believed that this effect of GTP is reliant upon guanine

nucleotide binding proteins, and, in fact, the GTP-binding proteins rhoK p21 and ras p21
can cause increases in calcium sensitivity (Hirata et al., 1992). While evidence points to

the possibility that agonist binding to G-proteins may elicit an inhibition of myosin light
chain phosphatase activity, the precise second messenger system by which this occurs has

yet to be revealed.

Other possible candidates for regulating calcium sensitivity in smooth muscle are the
calcium binding proteins caldesmon and calponin. Both caldesmon and calponin can be

phosphorylated by CaMK II or PKC, and calponin phosphorylation reverses the inhibition

of myosin ATPase imparted by caldesmon (Winder and Walsh, 1993). These proteins
appear to be complementary to one another, although they seem to be localized to
different actin filament sub-populations (North et al., 1994) Several findings have

pointed to caldesmon as a potential regulator of calcium sensitivity. In vitro preparations

of actin filaments and caldesmon show an increased sensitivity to calcium that directly
correlates with the amount of caldesmon present (Marston and Smith, 1984). In addition,

in a similar preparation, addition of anti-caldesmon antibodies negated this enhanced

10

sensitivity (Marston et al., 1988).

Possible Mechanisms for High-Economy of Contraction

The first suggestion that

smooth muscle was unique in its energy utilization was the finding in 1930 that
contracted smooth muscle could maintain developed force with very low energy output

(Bozler, 1930). Bozler also showed that although force was maintained at a constant

level, heat production decreased with time, indicating an increase in economy of
contraction as the contraction progressed. This finding is reasonable when the biological

function of the tissues comprising smooth muscle is taken into consideration. In later

work, Bozler went on to postulate that this high economy of smooth muscle contraction

was due to a reduction in the rate of detachment of myosin from actin during crossbridge
cycling (Bozler, 1977), but again, no mechanism was proposed for this slowing of the

crossbridge cycle. A possible explanation came with the finding that while myosin light
chain phosphorylation was necessary fbr smooth muscle contraction (Kamm and Stull,

1985; Hartshorne et al., 1989), high force could be generated and maintained with very
low levels of myosin light chain phosphorylation (Moreland and Moreland, 1987; Ratz
and Murphy, 1987). These works were and are still the foundation fbr current theories of

crossbridge cycling, most notably the latch hypothesis.

The latch hypothesis, proposed by Dillon et al. in 1981 and characterized further by Hai

and Murphy (1988,1989) and Murphy (1989), describes a "latch" state in which
dephosphorylated myosin cross-bridges remain attached to actin but cycle slowly to

11

produce slow increases in tension or maintenance of tension at low levels of myosin light
chain phosphorylation. This theory is based on the premise that there are 4 possible states
for myosin to assume: (M), unattached myosin; (AM), myosin attached to actin; (Mp),

unattached myosin which has been phosphorylated on the light chain; and (AMp),
attached and phosphorylated myosin (Hai et al., 1991). According to this theory, an
initial phosphorylation of the myosin regulatory light chain initiates the contraction in the

presence of increased intracellular calcium. This period of high MLC phosphorylation is
responsible for the rapid initial shortening velocity of smooth muscle tissue. As calcium

levels decline, myosin light chain kinase activity declines concomitantly; however, force
continues to develop because there is a transition from (AMp) to (AM). This continued
attachment of dephosphorylated myosin allows fbr a slower detachment constant from

actin and for maintenance of force by these crossbridges. Further, the small levels of
myosin that remain in the (AMp) state can continue to develop force, thus accounting fbr

the slower shortening velocity fbr smooth muscle contraction. Many mathematical
models have been produced using rate constants believed to be consistent with latch, and

these models accurately predict many parameters of smooth muscle contraction (Walker
et al., 1994); however, there is little direct experimental evidence fbr latch theory.

It has been further suggested that secondary mechanisms regulate the rate of high-affinity

cross-bridge cycling, or that mechanisms independent of myosin light chain
phosphorylation determine slow tension development in smooth muscle. Somlyo et.al.

(1989) proposed that slow force development is due to the balance of activity between
12

MLCK and protein phosphatase in the phosphorylation/ dephosphorylation of myosin

light chain. The subsequent identification of a specific myosin light chain phosphatase
(Shirazi et al., 1994; Somlyo and Somlyo, 1994), provided further evidence fbr this

hypothesis. Somlyo's hypothesis predicts that inhibition of myosin light chain
phosphatase would cause an increase myosin light chain phosphorylation, increase
myosin ATPase activity, and increase the rate of tension development. However, it was

found that inhibition of protein phosphatase activity, which according to this theory
would alter the relationship between force and MLC phosphorylation, had no significant

effects on this relationship (Siegman et al., 1989). This would imply that the high force
developed in the presence of only low levels of myosin light chain phosphorylation must

rely on a process other than dephosphorylation of the myosin crossbridges. (Siegman et
al., 1991). This discovery led to the suggestion of yet another means of crossbridge

regulation, namely, cooperativity. In this hypothesis, either low degrees of myosin light
chain phosphorylation turn on all the crossbridges fbr force production or only a few

select crossbridges are ever phosphorylated to generate force (Vyas et al., 1992). It is

uncertain how this process is regulated; however, both the actin filament itself and its
associated proteins have been proposed to play a part.

Several specific regulatory proteins have been suggested that may initiate or enable the

latch state. One of these is kinase related protein (KRP) (Collinge et al., 1992; Shattuck
et al., 1989) which has also been referred to as telokin (Ito et al., 1989; Gallagher and

Herring, 1991). Normally, in in vitro studies, unphosphorylated myosin dissociates into

13

its monomeric form upon addition of MgATP (Craig et al., 1983; Trybus et al., 1982).
However, in intact smooth muscle preparations, filamentous myosin remains intact even

at myosin light chain phosphorylation levels of less than five percent (Somlyo et al.,
1981; Gillis, et al, 1988), clearly indicating that other factors must be present in vivo that

stabilize unphosphorylated myosin. One of these factors is postulated to be KRP

(Shirinsky et al., 1993). The gene fbr KRP is found within the gene fbr myosin light
chain kinase (Collinge et al, 1992; Shoemaker et al., 1990) and is thought to be very
abundant in smooth muscle (Shirinsky et al., 1993). This protein, in vitrobinds to
unphosphorylated myosin and reverses the depolymerizing effect of MgATP, thus

allowing fbr retention of thick filament integrity even in an unphosphorylated state
(Shirinsky et al., 1993).

Another protein proposed to play a regulatory role in actin:myosin crossbridge cycling is

the actin-binding protein caldesmon. Caldesmon has a high binding affinity fbr actin
(Drabrowska and Galazkiewicz, 1986), and this affinity is sensitive to changes in

intracellular calcium levels. In addition, caldesmon interacts with myosin (Ikebe and

Reardon, 1988) and has been shown to inhibit both actin:myosin binding (Nowak et al.,

1989) and actin-activated myosin ATPase activity (Hemric et al., 1988; Lash et al., 1986).
Caldesmon inhibitory activity is reversed by Ca2+ and calmodulin (Lash et al.,1986) or by

its phosphorylation (Ngai et al., 1987). Because the phosphorylation of caldesmon is
markedly increased during maintained tension, it has been suggested that the

phosphorylation state of this protein functions as an on/off switch fbr the latch-state
14

cross-bridge cycling (Adam et al., 1989).

Additionally, two other thin filament-associated proteins, calponin and caltropin, have

been purported to play a role in crossbridge regulation. Calponin binds to both actin and

to calmodulin, and inhibits myosin ATPase activity in vitro„ and is distributed along the
actin filaments in a manner similar to that of troponin C in skeletal muscle (Takahashi et

al., 1988). Because it is the troponin-tropomodulin system that imparts cooperativity to
the crossbridge systems of skeletal muscle, a role fbr calponin in crossbridge regulation

was examined. It was found that the presence of calponin in in vitro systems increased
the amount of generated force while causing a decrease in myosin ATPase activity. From
this it was suggested that calponin may stabilize dephosphorylated crossbridges when the
myosin was in the (AM) state (Haeberle, 1994). The calponin induced inhibition of

ATPase activity is reversed by phosphorylation of the protein which decreases its affinity
fbr actin (Winder and Walsh, 1989). However, in vivo studies do not show significant

phosphorylation of calponin. As an alternative to phosphorylation, several studies have
suggested that caltropin may mediate the binding of calponin to actin (Willis et al., 1994;

Mani and Kay, 1993), although the nature of this mechanism has not been elucidated.

While all of these hypotheses focus on the properties of the actimmyosin crossbridge,
another area of work has focused on the role of the non-actin:myosin cytoskeleton in

explaining smooth muscle contraction. A significant development in this direction was
the analysis of the potassium-induced contraction of aortic smooth muscle on the basis of
15

its initial fast rise in tension followed by a.slow, strong development of tension and
maintenance of this tension (Wright and Hum, 1994). The fast phase of the contraction

has distinct similarities to the contraction of striated muscle contraction in that it occurs
in the presence of high intracellular calcium concentrations and high levels of myosin
light chain phosphorylation. Additionally, this portion of the contraction displays a

length-force relationship similar to that of skeletal muscle. In contrast to the fast

component, in the slow component of the smooth muscle contraction, which accounts for

approximately sixty percent of the total force generated, active tension is developed in the
face of diminishing intracellular calcium and minimal myosin light chain

phosphorylation. Also, the length-force relationship for this part of the contraction is
markedly different from that of either the fast phase of smooth muscle contraction or of

skeletal muscle contraction. These observations led to the suggestion that different

mechanisms contributed to the fast and slow components of smooth muscle contraction.

Rasmussen, et al. (1987) first proposed that the initial fast and secondary slow phases of

the contractile response are mediated by different mechanisms. This hypothesis
incorporates the observation that the actin cytoskeleton consists of two domains: a

continuous longitudinal arrangement of actin and myosin filaments with associated
regulatory proteins, and an arrangement of actin and intermediate filaments which are
attached to cell surface plaques and linked to intracellular dense bodies (Small, et al.,

1986; Cooke and Fay, 1972). It is proposed that the mechanism underlying the fast phase
centers on the interaction of actin and myosin; whereas, the secondary slow response
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involves a phosphorylation-mediated rearrangement of filaments to lengthen or shorten

the system via linkages between filamin and actin filaments at the dense bodies,
presumably effecting changes in the mechanical advantage within the system. Most

recently, Pratusevich, et al. (1995) have proposed that the long working range of smooth
muscle could be explained by a plastic rearrangement of myosin resulting in more myosin
thick filaments in series at longer lengths. They showed that tetanic force was below its

steady state after either tissue stretch or release but increased to a steady level within 5 or

6 tetanic contractions. They suggest that this phenomenon was due to temporary force
depression due to length change followed by reforming of the filament lattice to produce

optimal force development.

The Cytoskeleton

The smooth muscle cytoskeleton is comprised primarily of three

basic components: actin microfilaments, microtubules and intermediate filaments. These

three elements are the building blocks for the various structures present within the smooth
muscle cell, however, a much larger body of work exists on the location and function of
the actin and the intermediate filaments.

The actin cytoskeleton is involved in vesicle trafficking, cell division, muscle contraction

and cell motility (Barkalow and Hartwig, 1995) and can exist as either monomeric, G-

actin, or as filamentous, F-actin. The assembly of G-actin into F-actin is a two-step
process. The first step, nucleation, is the rate limiting step in polymerization and consists

of the association of three actin monomers into a nucleus. Once this nucleus is formed,
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rapid elongation of the filament occurs (Korn, 1982). The assembling actin filament
displays a polarity in its construction, this polarity may be demonstrated by decoration of

the actin filament with myosin. The myosin binds the actin filament at an angle, thus

producing what are commonly referred to as the barbed and pointed ends of the actin
filament. The barbed end of the actin filament has a higher affinity fbr monomeric actin

and therefore is kinetically favored fbr assembly.

The actin found in smooth muscle is structurally similar to the actin found in most cells

and has comparable molecular weight, ability to polymerize, to attach to myosin and to
activate myosin ATPase activity (Bray, 1972). There is also a high degree of conservation
of actin sequence within cell types with a 95 percent amino acid sequence homology

(Pollard and Cooper 1986). In vertebrate tissues, there are six distinct actin isofbrms, askeletal, a-cardiac, a-vascular, y-enteric, y-cytoplasmic and P-cytoplasmic. Each of
these is encoded by a distinct gene (Vandekerckhove and Weber, 1978; Reddy et al.,
1990), and three isofbrms are present in smooth muscle. The isofbrms found in smooth

muscle are a-actin, P-actin, and y-actin (Herman, 1993) and differ only in their Nterminus (Vandekerckhove and Weber, 1981). These isofbrms are categorized into

muscle (a and 丫- actin) and cytoplasmic (P and y- actin) divisions. Of the cytoplasmic
actins, P-actin is the most predominant, comprising up to thirty percent of the total

cellular actin complement (North et al., 1994). Within the smooth muscle cell itself^
there appears to be a functional compartmentalization of these isofbrms. Antibody

staining against P-actin produces diffuse staining throughout the cytoplasmic
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compartment, whereas antibodies directed toward the a and y-actin labels the myosincontaining contractile region (North et al., 1994). Small (1986) suggested that this

compartmentalization was a reflection of function. He hypothesized that contraction was
generated through the actin:myosin containing portion and resting muscle tone was

provided by the cytoplasmic actin containing portion of the cell. It has also been
proposed that the underlying mechanism for the development and maintenance of slow

smooth muscle contraction lies not in the actin:myosin portion of the actin cytoskeleton,

but in the P-actin containing, or cytoskeletal, fraction of the smooth muscle actin
cytoskeleton (Wright and Hurn, 1994; Battistella-Patterson et al., 1997). This theory was

precipitated by the discovery that inhibition of actin polymerization could selectively and
reversibly inhibit the slow phase of potassium-induced contraction (Wright and Hum,
1994).

Inhibition of actin polymerization is accomplished by the application of cytochalasins to
the smooth muscle tissue. Cytochalasins, from the Greek cyto, cell and chalasis,

relaxation, are a class of fungal metabolites first derived from cultures of
Helminthosporium dematioideum and Metarrhizium anisopliae in the late 1960's (Carter,
1967). These compounds were initially described to prevent cytoplasmic cleavage during
cell division, inhibit cell motility and restrict membrane ruffling. All these activities now
can be attributed to the actions of actin polymerization, however, at the time the loss of

these functions was explained as an effect of the cytochalasins on the cell to glass
interface of the cultured cells utilized (Carter, 1967). Later the cytochalasins were shown
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to cause micro filaments to lose their filamentous nature (Schroeder, 1970; Wessells et al.,
1971), and these micro filaments were then shown to be, in fact, actin filaments (Spudich
and Lin, 1972; Spudich, 1972). Cytochalasin inhibits actin polymerization by binding to

the barbed end of actin filaments, inhibiting any addition of actin monomer to the existing

filament (Cooper, 1987).

It was clearly demonstrated that smooth muscle contraction could be inhibited by

treatment with cytochalasin, however, it was unknown if this was through the effects of
cytochalasin on the polymerizing actin cytoskeleton or due to some other effect of the

drug (Wessells, et al, 1971). Because stable actin, such as is found in striated muscle, is
impervious to depolymerization by cytochalasin, and because the cytoskeletal actin

compartment was not believed to play a role in smooth muscle contraction, it was
suggested that the mechanism of action of cytochalasin on smooth muscle contraction

was through the blockade of calcium influx (Dresel and Ogbaghebriel, 1988), blockade of
glucose uptake (Dresel and Knickle, 1987), inhibition of myosin light chain
phosphorylation or inhibition of myosin ATPase activity. Each of these possibilities has

been addressed. Obara and Yabu (1994) showed that treatment of smooth muscle tissues

with cytochalasin at a concentration that induced maximal inhibition of the contraction,
had no effect on calcium currents, myosin light chain phosphorylation or myosin ATPase
activity in response to high potassium contraction. This work was verified in carbachol

treated tissues and in addition, the absence of an effect of cytochalasin on glucose
transport at the concentration necessary to produce maximal inhibition was shown (Tseng
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et al., 1997). At the same time that these possibilities were being refuted, it was

suggested that it was the effect of cytochalasin on the actively polymerizing actin

cytoskeleton that was eliciting inhibition of slow phase contraction (Wright and Hum,
1994). This, in addition to the finding that skeletal and cardiac muscles are unaffected by

cytochalasins has led to the proposal of a new theory (Battistel 1 a-Patterson et al., 1997).
Because the stable actin of skeletal and cardiac muscle is not affected by cytochalasin, it

was reasoned that the fast phase, which is similarly unaffected by cytochalasin, was
produced by a mechanism comparable to sliding filament based systems. This hypothesis

discusses the role of the dynamic actin cytoskeleton as a potential player in the
development of slow smooth muscle contraction, however, the exact mechanisms by

which this occurs have yet to be elucidated.

There are also several actin-binding proteins that also bind to calcium and that are
believed to play a role in contractile function. The first of these, caldesmon has been

discussed above in relation to its contributions to crossbridge regulation and to calcium
sensitivity. The caldesmon of smooth muscle, when isolated, is found to be associated

tightly with the actin filaments (Marston and Lehman, 1985), and when examined in vivo

is found to be incorporated into the actin filaments of the contractile domain (Furst et al.,

1986; North et al, 1994) in an actin to caldesmon ratio of sixteen to one (Marston, 1990;
Lehman et al., 1993). The caldesmon molecule is a long, rod-like structure (Mabuchi and
Wang, 1991), and nuclear magnetic resonance (NMR) analysis indicates that it is

composed of several rod sections linked by flexible hinge regions (Stafford et al., 1990).
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The caldesmon molecules are oriented in an extended form along the actin filament and

beside tropomodulin. This organization provides the basis fbr the function of caldesmon
in contraction (Marston and Huber, 1996). Several groups have shown, in vitro, that
caldesmon affects actin motility (Shirinsky et al., 1992; Haeberle et al., 1992; Okagaki et
aL, 1991), and more recent work has proposed that this inhibition is due to a switching off
of actin filaments in units as opposed to affecting actin:myosin interactions on a single

filament basis (Fraser and Marston, 1995). This has led to the proposal that caldesmon,

in addition to its effects on calcium sensitivity and crossbridge dynamics, may act as

troponin does in skeletal muscle to regulate actin movement (Marston and Huber, 1996).

In addition to the actin cytoskeleton, there is another portion of the smooth muscle cell

that has been closely examined as playing a role in the contractile process. The
intermediate filaments are a diverse group of proteins that play many roles within the cell.

Upon electron microscopic analysis, there appear many electron-dense regions, these are
referred to as either membrane associated dense bodies (MADBs) or as cytoplasmic dense

bodies (CDBs), and are both comprised primarily of intermediate filaments (Stromer,

1995). The MADBs are, as their name implies, found at the cell periphery and have been

shown to contain a-actinin (Fay et al., 1983; Geiger et al., 1985), vinculin (Geiger et al.,
1985; Volberg et al., 1986), metavinculin (Belkin et al., 1988), talin (Volberg, et al,

1986), filamin (Small et al., 1986), plectin (Wiche et al., 1983) and actin. CDBs are
found in the interior of the cell and contain a-actinin (Fay et al., 1983; Small et al, 1986),

desmin (Berner et al., 1981), filamin (Lehman et al., 1987) and vimentin (Schmid et al.,
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1982). Both of these structures are believed to anchor actin filaments, and it is possible
that they are important to smooth muscle contraction. Both desmin (Inagaki et al., 1988)

and vimentin (Inagaki et al., 1987) can be phosphorylated by protein kinase C (PKC), and
this phosphorylation is related to a disassembly of the filaments. Additionally, it has been
shown that smooth muscle desmin is phosphorylated in response to agonist simulation of

contraction (Park and Rasmussen, 1986), and that this phosphorylation is reversible upon

relaxation of the tissue (Barany et al., 1992). This reversible phosphorylation supports
the theory that there is a domain of smooth muscle comprised of filamin, actin and

desmin (FAD), which is phosphorylated during smooth muscle contraction (Rasmussen et
aL, 1987). This phosphorylation would allow partial depolymerization of the filaments

and a rearrangement of the cytoskeleton to maintain force with low energy expenditure.

While both the role of the actin cytoskeleton and the intermediate filaments in smooth
muscle contraction have been widely studied, the role of the microtubules in smooth
muscle physiology has largely been ignored. The microtubules are responsible fbr many

different functions including formation of the mitotic spindle, axonal and dendritic
extension in neurons, maintenance of intracellular organization, transport of various

compounds and organelles (Avila, 1991) and cell motility (Bershadsky and Vasiliev,
1993). The microtubules exhibit the ability to extend and retract by polymerization and
depolymerization, respectively. This polymerization or depolymerization is

accomplished by the addition or removal of tubulin monomers (Sullivan, 1988). Like
actin filaments, the microtubules have a distinct polarity. At the plus end the addition of
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tubulin monomers occurs at a greater rate than at the minus end. There are three types of
tubulin that comprise the microtubule, a, P and y. The a and P-tubulin form dimers and

these dimers then attach to the growing microtubule. 丫-Tubulin is found at the
centrosome and forms the nucleation site fbr further polymerization (Oakley and Oakley,
1989; Zheng et al., 1991). This site is often referred to as the microtubule organizing

center (MTOC). The MTOC not only serves as a point of origin fbr all the cellular
microtubules, it also maintains microtubular polarity throughout the cell because it

constitutes the minus end of the microtubule. This degree of organization ensures that

microtubular polymerization can only occur in a direction away from the MTOC

(Brinkley, 1985). The importance of this polarity can be seen in the examination of two
proteins associated with the microtubules. In order fbr the microtubules to fulfill many of
the functions that they perfbnn, there must be a means to move things along the
microtubules in both directions. This is accomplished by microtubule associated motor

proteins, notably kinesin and dynein. Both of these proteins consist of a heavy chain and
of a light chain, and in both cases it is the heavy chain that binds to the microtubule and
generates force through hydrolysis of ATP, while the light chain is responsible for
binding a specific "cargo”. A major difference between the two motor proteins is based

on the polarity of transport along the microtubules; kinesin is a plus-end oriented motor,
moving away from the MTOC, and dynein is a minus end-directed motor, moving toward
the MTOC. This type of system allows fbr specific and directed bi-directional transport
of compounds and organelles.
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In the study of various functions of the microtubules in living systems, a method that has
been widely employed has been the use of the drug colchicine, which causes
depolymerization of the microtubules into free tubulin. In early studies on cultured

skeletal muscle cells, colchicine was found to cause a disruption of the cellular

morphology, producing

within the cytoplasm (Godman, 1955). In addition,

the application of colchicine to these cells caused a loss of mitochondrial orientation,

however, both of these effects were reversible with the removal of colchicine (Godman,

1955). At the time, the microtubules had not yet been discovered, but it had been
theorized that colchicine "might effect a folding of elongated protein chains from fibrous

to globular,, (Ostergren, 1944), or that it acted by causing a "dissociation of micellar

aggregates by directly disrupting their linkages,, (Simms and Sanders, 1942). It is now
known that colchicine works by binding to the polymerized tubulin which results in

depolymerization of the microtubule.

Employment of in vivo Antisense Techniques

The application of antisense

oligonucleotides to block synthesis of specific proteins has become increasingly common.
These synthetic oligonucleotides are complementary to a specific mRNA and by binding

the mRNA prevent its translation to protein or targets the RNA duplex for degradation.
This allows fbr a highly specific means of reducing the amounts of a single protein.

Because oligonucleotides are hydrophilic, they do not readily pass through the cell
membrane. In order to improve the efficiency of uptake, the oligonucleotides must either

be modified or conjugated to another compound to increase their hydrophobicity and,
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therefore, increase their membrane permeability. Many methods have been employed to
accomplish this. One method involves a pre-incubation of the oligonucleotides with a
cationic lipid solution. With gentle mixing and a short incubation period, the
oligonucleotides become encapsulated within micelles of the cationic lipid which may
readily penetrate the membrane (Schreier, 1994). Another method that has been used is

the incorporation of the oligonucleotides into a detergent-like pluronic gel (Simons et al.,
1992). In this case, the low hydrophobicity of the oligonucleotides is compensated for by

the permeabilization of the membrane by the pluronic gel. This method is used primarily
fbr in vivo applications because the consistency of the gel allows fbr localized application

of the oligonucleotides. A third method utilizes a virus-mediated incorporation of
sequence coding fbr RNA that is complementary to a specific message into the cells (Lee
et al., 1996). This method is used in both in vivo and in vitro situations and may result in

widespread delivery of antisense oligonucleotides to tissues and organs in vivo.

Kinases of Smooth Muscle Contraction

There are numerous kinases that are abundant

in smooth muscle, however, only a few have been distinguished as playing a role in the
generation and regulation of contraction. The first of these, myosin light chain kinase
(MLCK), is the principal kinase associated with smooth muscle contraction. The role of
myosin light chain kinase in smooth muscle contraction has been discussed above.

Briefly, upon agonist stimulation or depolarization of the smooth muscle tissue, there is a
rise in intracellular calcium levels which precipitates the association of calcium with

calmodulin. This complex then, in turn, binds to MLCK. Binding of calcium:calmodulin
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to MLCK activates the kinase, which then is able to phosphorylate the myosin regulatory

light chain. Light chain phosphorylation results in the initiation of crossbridge cycling
and subsequent contraction. Myosin light chain kinase is a 130 kDa protein (Gallagher et

al., 1991) that exists in two distinct forms: those found in skeletal muscle (Herring et al.,
1992) and those found in smooth muscle (Gallagher et al., 1991; Kobayashi et al., 1992).
It is present in much higher amounts in smooth muscle (Stull et al., 1986). The N-termini

of these kinases contains the actin binding region of the protein (Kanoh et al., 1993) and

is highly conserved within both muscle types and between species (Stull et al., 1996).
The central region of each kinase is highly variable with considerable differences between

species being common. The catalytic core immediately follows the central region and is
not only highly homologous within myosin light chain kinase forms, but is also similar to
the catalytic regions of several other kinases (Knighton et al., 1991; DeBondt et al., 1993;

Zhang et al., 1994). The C-terminal region of the kinase is the regulatory domain, and

within this portion of the kinase, there are two specific functions, autoinhibition and
calmodulin binding. The autoinhibitory region of the regulatory domain is adjacent to the

catalytic core and is folded over the catalytic region, blocking activity until calmodulin
binding causes a conformational change that removes the inhibition (Kemp et al., 1994).
Much of the work done to examine the function of MLCK has involved the use of
inhibitors of the kinase, and many of these inhibitors are targeted to the autoinhibitory
domain (Kemp et al., 1991). Early attempts to inhibit MLCK utilized its dependence

upon calmodulin and acted to bind free calmodulin. These quickly lost their appeal when
it was discovered that they were also inhibiting another kinase involved in smooth muscle

27

contraction, calcium/calmodulin dependent protein kinase (Asano and Stull, 1985;

Nakanishi et al., 1992).

The calcium/calmodulin dependent protein kinase (CaMKII) family consists of four

isofbrms (a, p, y and d) regulated by the complex of calcium and calmodulin, and also by
autophosphorylation (Hanson and Schulman, 1992). The kinase is responsible fbr many

functions, including neurotransmitter release (Llinas et al., 1985), catecholamine
synthesis (Waymire et al., 1988), mitosis (Baitinger et al., 1990), transcription (Sheng et
al., 1991), vascular smooth muscle cell migration (Pauly et al., 1995) and smooth muscle

contraction (Edelman et al., 1990; Tansey et al., 1992). It seems that there is a
partitioning of isofbrms with the a and p forms expressed almost exclusively in the brain

and the 丫 and 6 isofbrms found in peripheral tissues (Bulleit et al., 1988; Tobimatsu and

Fujisawa, 1989), with the d isofbrm being predominant in smooth muscle (Schworer et
al., 1993). Two of the possible effects of CaMKII on smooth muscle contraction have
been discussed above. The first of these is an effect of phosphorylation by CaMKII on
myosin light chain kinase. When MLCK is phosphorylated by CaMKII in vivo the

affinity of MLCK for calmodulin is decreased and the calcium/calmodulin threshold fbr

activation of MLCK is raised (Stull et al., 1990). In addition, if the CaMKII specific
inhibitor, KN-62 is used in these preparations, the phosphorylation of myosin light chain

by MLCK is potentiated, indicating that there is an inhibitory effect of CaMKII

phosphorylation on MLCK activity (Tansey, et al., 1992). Calmodulin kinase II also has
been shown to co-purify with caldesmon in smooth muscle preparations (Ngai and Walsh,
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1985) and to phosphorylate caldesmon. This phosphorylation reverses the inhibitory
effect of caldesmon on myosin ATPase activity (Ngai and Walsh, 1987). One problem

with the theory that CaMKII is responsible fbr caldesmon phosphorylation during
contraction is that the sites phosphorylated by CaMKII in vitro do not correspond to sites

phosphorylated in intact tissues (Adam et al, 1989, 1992). The sites that are
phosphorylated in vivo are the same as the sites phosphorylated by another kinase
purported to be involved in smooth muscle contraction, mitogen activated protein (MAP)
kinase (Adam et al, 1992). This suggests that if CaMKII is involved in regulating
caldesmon phosphorylation and subsequently smooth muscle contraction, these effects

may be due to the effects of CaMKII on MAP kinase (Singer et al, 1996).

Mitogen activated protein (MAP) kinase is a part of a family of serine/threonine kinases
that are activated by growth stimuli. These kinases are present in almost all tissues and

are activated only when phosphorylated on both tyrosine and threonine. This
phosphorylation can be provided by the actions of a variety of agonists and stimuli
including insulin (Clarke, 1994; White and Khan, 1994), insulin-like growth factor (Lamy

et al, 1993), platelet derived growth factor (Chao et al., 1994), vasopressin, angiotensin II,
growth hormone and muscarinic agonists (Alessindrini et al., 1992; Campbell et al.,

1992; Yin and Yang, 1994). The actions of MAP kinase in smooth muscle are proposed

to be via its phosphorylation of caldesmon (Adam et al., 1992). As discussed above,
caldesmon inhibits myosin ATPase activity and its phosphorylation causes this inhibition
to disappear. Additionally, this phosphorylation may alter the dynamics of actin
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polymerization and organization in the smooth muscle cells (Adam, 1996). However, the
pathway that activates MAP kinase in smooth muscle is not known. In many instances,
MAP kinase activation is accomplished via membrane associated G-proteins that then

transduce the signal to MAP kinase, but the exact signaling pathways involved are not yet

entirely clear (Adam, 1996). One possible route of activation fbr MAP kinase is via
another kinase, protein kinase C (Khalil and Morgan, 1993).

The protein kinase C family is a large, multifunctional group consisting of at least eleven

isofbrms divided into three subgroups based on their structure and activation
requirements (reviewed by Ohno et aL, 1991). The "conventional" PKCs (a, p, y)

require calcium, phosphatidyl serine, and diacylglycerol fbr full enzyme activity. The
"novel" PKCs (e, d, 0, T|) are calcium independent, and the "atypical" PKCs (C, i, X) are

both calcium and diacylglycerol -independent but both require phospholipid, the only
cofactor shared among all three groups. Each cell type has its own unique complement of
PKC isofbnns (Dekker and Parker, 1994). Additionally, within a given cell type, PKC

may be involved in the regulation of a variety of diverse functions ranging from growth
and differentiation (Nishizuka, 1992) to secretory activity (Kiley et al., 1992), motility

(Bershadsky and Vasiliev, 1993), and signal transduction. The presence of multiple

isofbrms regulating diverse cellular functions suggests that each isofbrm phosphorylates a
specific substrate and that redundancy is limited or absent (Mochly-Rosen, 1995). This,
in turn, implies a high level of PKC isofbrm compartmentalization and regulatory control

of activation.
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The fundamental questions surrounding the regulation of PKC activity are: (1) the
mechanism(s) underlying its movement to isofbrm-specific sites in the cell, (2) its
activation, and (3) substrate specificity. Prior to cellular stimulation, PKC is found either
diffusely throughout the cytoplasm or localized within particular regions of the cell

(Mochly-Rosen, 1995). In order to be activated, PKC must be translocated to the cellular
membranes. PKC translocation is both rapid and highly directional with detectable

migration of the isofbrm observed within seconds after stimulation and peak movement

achieved within an interval of minutes (Haller et al., 1990). The efficiency and
membrane-directed nature of PKC translocation is thought to be due to a calcium-induced

conformational change in the kinase which exposes hydrophobic regions within its

structure that impart increased affinity fbr membrane binding sites (Bosca and Moran,
1993). There is now considerable evidence suggesting that the stable interaction of PKC

with the membrane is achieved through binding to isofbrm-specific anchoring proteins
termed receptors fbr activated C-kinase (RACKs) (Mochly-Rosen, 1995). Hence, it is

thought that following stimulation-induced increases in intracellular calcium PKC
migrates, presumably by diffusion, to membrane bound anchor proteins. The weak,
specific interaction between the kinase and the anchor protein then serves to tether the
kinase in close association with substrate achieving differential compartmentalization and

isofbrm specificity of substrate phosphorylation.

The PKC isofbrms found in vascular smooth muscle (a, P，e, 6, 0 (Andrea and Walsh,

1992) have been proposed to play a key role in the proliferation, differentiation
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(Montesano and Orci, 1985), and contractile properties (Rasmussen et al., 1987) of these
cells. The impact of PKC on contraction of vascular smooth muscle was indicated by the

discovery that phorbol esters, analogues of diacylglycerol, caused a slowly developed but
robust and sustained contraction (Danthaluri and Deth, 1984). Furthermore, PKC is

tonically activated in response to a variety of contractile stimuli (Haller et al., 1990;

Singer et al., 1992), while inhibition of PKC activity blocks or attenuates the contractile

response to different agonists (Merkel et al., 1991; Shimamoto et al., 1993; Wright and
Hurn, 1994). The down regulation of PKC protein by long-term exposure to phorbol

ester has been demonstrated to attenuate the contractile response of smooth muscle to
different agonists (Merkel et al., 1991). The change in the pattern of phosphoproteins

during contraction is suggestive of a role fbr PKC in the slow phase of contraction unique

to smooth muscle in which tension is slowly developed and may be maintained at a
constant level fbr extended intervals (Haller et al., 1990). Other work has further shown

that the application of staurosporine at a concentration (8xlO'9M), which should

specifically inhibit PKC activity, caused the selective inhibition of slow tension
development by rat aortic smooth muscle (Wright and Hum, 1994). Taken together, the
evidence indicates that PKC is involved in the slowly developed and maintained tension

uniquely characteristic of contractile function in smooth muscle.

While it is clear that PKC may play an important role in the contractile response of
vascular smooth muscle to various agonists, the exact mechanism by which this is

accomplished remains uncertain. Rokolya et al, (1991) have shown that myosin light
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chain phosphorylation levels increased upon the addition of phorbol ester to tissues

precontracted with high potassium. During sustained potassium contractions,
intracellular free calcium levels decline (Murphy et al, 1990) and myosin light chain

kinase, which requires calcium for its activity, may be inactivated. Interestingly, even
though PKC has been shown to phosphorylate MLC at sites distinct from those

phosphorylated by MLCK, the phosphorylation of MLC observed with phorbol ester

addition to potassium contracted tissues was consistent with MLCK activity. This
suggests that under some conditions PKC may play a direct or indirect role in the

activation of MLCK. There is also evidence that PKC phosphorylates a number of
cytoskeletal intermediate filament and regulatory proteins (Rasmussen et al., 1987). It

was proposed that these phosphorylations result in a stabilization of the cytoskeletal
domain containing filamin, actin and desmin which could contribute to the maintenance
of active force. Another possibility is that PKC exerts its influence on smooth muscle via
its effects on mitogen activated protein kinase. It has been shown that MAP kinase

undergoes a concurrent translocation with PKC in freshly isolated ferret aortic smooth
muscle cells (Kahlil and Morgan, 1993). Following an initial membrane directed
movement, MAP kinase is transported back into the cytoplasm. This re-distribution of

the MAP kinase could explain how activated PKC, which remains associated with the
membrane during contraction, can exert an influence on the contractile elements located

throughout the cell and how the activation of MAP kinase in smooth muscle may be
accomplished.
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Summary

While, at first glance, smooth muscle appears to be an uncomplicated tissue, the

mechanisms of smooth muscle contraction remain, for a very large part, a mystery.
Unlike striated muscle, where form follows function, smooth muscle lacks any apparent

contractile mechanism but it does appear that there may be some degree of applicability
of a modified version of sliding filament mechanics to smooth muscle contraction.

According to this hypothesis, smooth muscle contraction is initiated by a rise in
intracellular calcium produced by agonist stimulation or to depolarization. This rise in
intracellular calcium concentrations allows fbr the association of calmodulin with
calcium, and this calcium:calmodulin complex then binds to myosin light chain kinase,

activating the enzymatic properties of the protein. This is the first step in the mechanical

generation of force. Myosin light chain kinase, when turned on, acts to phosphorylate a
serine residue on the myosin regulatory light chain. When phosphorylated, the light chain
permits the association of the myosin head with an actin filament, this induces subsequent

ATPase activity and crossbridge cycling. There are many characteristics of the smooth

muscle contraction that do not fit neatly within the constraints of this process, however,

there are also many points fbr differential regulation within the system.

The inconsistencies between the experimentally obtained facts of smooth muscle
contraction and the sliding filament-like theories proposed to explain the process which
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are most often addressed include lack of calcium dependence, low energy consumption
and high force generation with low cellular myosin content. The lack of calcium
dependence is explained by the presence of calcium sensitizing agents within the cell that

are activated in response to certain contractile stimuli but not to others. Low energy

requirements by actively contracting smooth muscle are interpreted within the framework
of a mathematical model. Latch theory predicts that unphosphorylated myosin can
maintain its attachment to actin, thus lowering the energy consumption for slowly
developing and maintained contraction. However, experimental evidence fbr actin

binding by this unphosphorylated myosin in vivo is lacking. The cooperative theory of

myosin binding could possibly explain the low myosin light chain phosphorylation levels
found with contraction, but is hard to verify beyond conjecture and extrapolation. That
smooth muscle can develop at least as much tension as striated muscle with fractional

levels of cellular myosin content is examined as a function of the myosin molecule itself.
The myosin of smooth muscle may have a longer duty cycle, enabling longer periods of

attachment, or it may not. Low myosin contraction could also be due to smooth muscle

myosin being arranged into different type filaments that striated muscle myosin, thus

allowing for longer filaments and greater actin:myosin interaction. The problem with
many of these theories is that they are narrow in scope. Each of the proposed

explanations for smooth muscle contraction addresses only one particular contractile
property and, in each case, proposed mechanisms fbr explaining smooth muscle

contractile properties are couched in terms of the existing framework of sliding filament
theory while ignoring other systems in the smooth muscle cell that may play a
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considerable role in the generation and maintenance of smooth muscle contraction.

Recent work investigating the role of the smooth muscle cytoskeleton in contraction is
beginning to suggest that the examination of aspects of this system beyond those

commonly acknowledged to be a part of the contractile process may give increased

insight into the exact mechanisms of smooth muscle contraction. With evidence fbr the

involvement of many varied cytoskeletal systems, it seems unlikely that the nonactinzmyosin cytoskeleton does not play an important role in the contraction. The

dynamic actin cytoskeleton has been shown to play an integral role in slow phase
contraction and to be the location of numerous accessory intermediate filament proteins

such as filamin and desmin. In addition, the microtubular cytoskeleton is beginning to

emerge as a potential component of the smooth muscle contractile machinery. Many
elements of the cytoskeleton have also been identified as either targets of phosphorylation

during the course of the contraction or as a transducing elements in the activation and
action of kinases.

Protein kinases of smooth muscle, other than myosin light chain kinase, are also
beginning to be recognized as important potential players in the smooth muscle
contraction. For example, several kinases, including calcium dependent calmodulin

kinase, which have direct effects on the regulation of the established elements of

contraction, along with other kinases are now being recognized to have effects via other
pathways. Mitogen activated protein kinase is established as playing a role in contraction
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as its inhibition produces effects on the force developed by smooth muscle. However, the
exact mechanism of its actions are not clear. In addition, protein kinase C is widely
recognized to be directly involved in smooth muscle contraction. Inhibition of this

enzyme has significant effects on contraction, but its exact mode of action is uncertain.
PKC has been shown to be capable of phosphorylating myosin light chain and myosin

light chain kinase and has also been shown to potentially play a role in the regulation of

the MAP kinase cascade. It may be via one or all of these pathways that PKC exerts its
effects, or it may be through another route entirely.

In order to fully understand the mechanisms of smooth muscle contraction, the
importance of and the role for every system within the cell must be accounted for. Work

is now progressing toward this end, and promises to bring an understanding to the

mechanisms underlying smooth muscle contraction that extend beyond sliding filament

theory.
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II. Methods

Research Goals. The primary goal of this work was to better understand the mechanisms
underlying vascular smooth muscle contraction and the regulation of these mechanisms.

This was accomplished by: 1) examining the role of the non-actin:myosin cytoskeleton in
vascular smooth muscle contraction; 2) assessing the importance of several kinases in the
contractile process, and 3) integrating the knowledge gained concerning these two

systems of the smooth muscle cell.

Examination of the non-actin:myosin cytoskeleton was accomplished in a series of
experiments examining the effects of manipulation of the actin and microtubule

components on smooth muscle contractile properties. Because it became apparent that
the microtubules played an important role in slow force development by smooth muscle,
further work was conducted to investigate the role of the microtubule associated motor

protein kinesin in the contractile process. Because there are no pharmacological
inhibitors available that specifically inhibited kinesin activity, antisense oligonucleotides

were utilized to reduce the amount of kinesin protein produced in cultured tissues.
Additional work included an in vivo analysis of the effects of antisense inhibition of

kinesin synthesison the contractile properties of smooth muscle.

The roles of the various kinases of smooth muscle were examined in a series of

contractility experiments utilizing pharmacological inhibitors specific to the targeted
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kinases. These studies indicated PKC as being important to development of the slow
component of contraction. Protein kinase C must be translocated from its resting location
in the cytoplasm to cellular membranes fbr its full enzymatic activation. Because the

microtubules are involved in the directed transport of many cellular components, and
because the effects of PKC inhibition and microtubular disruption produced similar
effects on smooth muscle contraction, it was reasoned that the microtubules may be

acting as a transport system fbr the directed translocation of PKC following agonist

stimulation. The viability of this hypothesis was examined by observing PKC
translocation in response to phorbol ester and the changes in its translocation incurred by
disruption of the cytoskeleton.

Animals. Twelve week-old male Sprague Dawley rats (Hilltop Laboratories, Scottsdale,
PA) were used fbr all experiments. Animals were maintained at an ambient temperature

of 23°C ±2°C and a 12:12hr light:dark cycle. Purina Rat Chow and fresh tap water were
freely available.

The Effects of Cytoskeletal Disruption on Smooth Muscle Contractility

The initial goal fbr this series of experiments was to expand upon previous work which

suggested a role fbr the dynamic actin cytoskeleton in smooth muscle contraction. The
current work examined the functional and mechanical implications of cytoskeletal actin
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disruption. Because this work confirmed a role fbr the non-actin:myosin cytoskeleton in
smooth muscle contraction, a second part of the smooth muscle cytoskeleton, the

microtubular portion, was examined in a similar fashion. Based on the results of these
experiments, the role of the microtubule associated motor protein kinesin on contraction

was assessed.

Tissue Preparation. The evaluation of in vitro contractile responses was performed as
previously described (Huang et al, 1988). Rats were anesthetized with ketamine:xylazine
(21:9 mg/kg), exsanguinated by cardiac puncture, and the thoracic aortae were surgically

removed and transfeired immediately to warmed, oxygenated buffer, cleaned of adherent
tissue, and cut into rings 〜0.3 cm in width. Rings were mounted at 1 g of passive

tension in 25 ml glass organ baths containing Krebs buffer [ (in mM) 118 NaCl, 4.7 KC1,
1.5 CaCl2, 25 NaHCO3, 1.1 MgCl 2, 1.2 KH 2PO4, and 5.6 glucose; pH 7.4] maintained

at 37°C and aerated with 5% CO2 in O2.

Tissues were allowed to equilibrate a minimum

of 1.5 hr before reference contraction. Contractions were recorded using a force

transducer (Grass FT03) connected to a Grass polygraph (7D). The analysis of the
contractile response was performed as previously described (Wright and Hum, 1994).

The separation of the development of force into fast and slow components was based on
the rate of increase in tension (Figure 2). The portion of the contractile response in which
the rate of increase in tension exceeded 1.0 g/min. was designated the fast response.
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Tension

Slow Response
Fast Response
Passive Tension
(preload)

10.0 min

Figure 2
Representative tracing of K+ induced smooth muscle contraction. Tissues
were equilibrated at a passive tension of 1g prior to induction of contraction by the
hypertonic addition of 80mM K*. The contraction can be divided into two phases, an
initial fast phase characterized by the rapid development of active tension, and a
secondary slow phase in which active tension is developed at a slow rate and then
maintained.
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Passive Tension-Length Determinations. Tissues were excised and mounted as for
contractile measurements. Following equilibration at 1 g of passive tension, the tissue

lengths were measured using a micrometer caliper (Walter Stem, Inc., NY). The preload
of each tissue was then raised from 1 g to 20 g in increments of 5 g. At each preload, the

tissues were brought to a stable baseline and monitored for an additional 15 minutes to
ensure maintenance of baseline prior to measurement of tissue length.

Inhibition of Actin and Microtubule Polymerization. AH tissues were initially

equilibrated for 2 h at a passive tension of 1 g prior to reference contraction by the

addition of a hypertonic K' solution (80 mM) to the baths. Tissues were returned to
baseline by washing with fresh buffer, and the passive tension was adjusted to preloads of

1, 5, 10, 15, or 20 g. Once the tissues maintained a stable baseline at the set preload, all
tissues were again contracted by the addition of 80 mM KL To determine the effects of

selective disruption of the microtubules or inhibition of actin cytoskeletal remodeling on
active tension development at increasing passive tension preloads, colchicine (25 jig/ml)

was added 20 minutes before contraction and cytochalasin B (2 p.g/ml) was added 5

minutes prior to contraction. Because a large population of the microtubules are resistant
to colchicine but are disrupted by cooling (Tsutsui et al., 1994), an additional experiment

was conducted to examine the effect of this portion of the microtubular system on active
tension. Tissues were excised and hung at 10 g passive tension for contractility
measurements as described above. After a reference contraction to 80 mM K+, tissues

were rapidly (〜1 minute) cooled to 0° C. Tissues remained at this temperature for 60
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minutes, and then were quickly (〜2 minutes) rewarmed to 37° C in the presence or

absence of colchicine (25 |ig/ml) with the drug added 20 minutes before rewarming

began. Following return to 37° C, the tissues were reequilibrated fbr one hour and were

then contracted with 80 mM K+. Effectiveness of each treatment on disruption of the
cytoskeleton was verified by microscopic analysis.

Microscopy. In order to verify the effects of actin and microtubule disrupting drugs, rat

aortic smooth muscle cells in fifth through eighth passage were grown on glass coverslips

until the cells had attached and begun to spread. The cells were untreated (vehicle) or
were exposed to cytochalasin B or colchicine. To prepare fbr staining, the cells were

fixed and permeabilized in ice cold acetone fbr one minute. For visualization of
cytoskeletal components, fluorophore labeled primary antibodies (Sigma

Immunochemicals) to smooth muscle actin and tubulin or TRITC labeled phalloidin were
used. The preparations were mounted on a Nikon Diaphot microscope, and confocal

microscopy was performed with a BioRad Model 1024 scanning system using a
krypton/argon laser. Final micrographic images were built by projecting serial Z-plane
image acquisitions and were analyzed using Lasersharp and Confocal Assistant software

(BioRad, CA).

Oligonucleotide Synthesis and Preparation. Antisense and sense oligonucleotides
directed toward the kinesin heavy chain were synthesized on an Applied Biosystems 394

DNA/RNA Synthesizer. Each oligonucleotide incorporated phosphorothioate
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modifications to aid in stabilizing the oligonucleotide by making it more resistant to

nuclease degradation (Wagner et al., 1993). The antisense sequence used was
GCCGGGTCCGCCATCTTTCTGGCAG (Amartunga et al., 1993). Oligonucleotides

were purified by ethanol precipitation, resuspended in TE bufter quantified by A260 (pH
8.0), and stored at 4°C.

Blockade of Kinesin Protein Synthesis. Vessels were treated in vitro with the

oligonucleotides to block kinesin protein synthesis. Tissues were cultured as previously
described (Wright et al., 1996). Briefly, an aorta was excised, cut into rings as above,

and the luminal surfaces of the rings were gently rubbed to remove the endothelial cell
layer. The aortic rings were then transferred into Leibovitz's L-15 media (5 ml)

supplemented with rat plasma (5 ml) and penicillin/streptomycin (1050 U/1050 pig) and
incubated at 37°C in an atmosphere of 5% CO2 in air fbr 24 hours. The oligonucleotides
(1-2 umol in TE pH 8.0) were mixed with Lipofectin® (100 p.1) prior to addition to the
culture media. Lipofectin® acts to aid the passage of the oligonucleotide into the vessel

wall by incorporating the oligonucleotide into liposomes. Plasma was added last to limit

the incorporation of plasma components into the liposomes. Following a 24 hour
incubation, tissues were mounted for contractility determinations and contracted at 1 g of

passive tension with 80 mM K+.

Immunoblot Analysis. In order to determine if the kinesin protein levels were reduced

in response to the antisense oligonucleotide treatment, aortae were homogenized in
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buffer (pH 7.5, 20 mM Tris-HCl, 10 mM EGTA, 2 mM EDTA, 2 mM PMSF) at 4°C.
Protein concentrations were determined by the BCA®(Pierce) protein assay. Samples of

equal protein concentrations were denatured in sample buffer (50 mM Tris, 10% glycerol,
20 mM DTT) before being subjected to 10% SDS-PAGE. Proteins were electrically
transferred to Hybond® nitrocellulose membrane (Amersham). The membrane was

incubated fbr an hour at room temperature in blocking solution (5% nonfat dry milk in

phosphate buffered saline, pH 7.5, containing 0.5% Tween-20). A 1:2000 dilution of

monoclonal anti-kinesin heavy chain antibody (Sigma) was added fbr 1 hour at room
temperature. The blot was washed several times in PBS-0.5% Tween followed by a 1
hour incubation with a 1:1000 dilution of rabbit anti-mouse horseradish peroxidase
conjugated secondary antibody. Following incubation, the blot was again washed with

PBS-Tween. Immunoblots were visualized using the ECL Western blotting detection
system (Amersham) and quantified by 2D-densitometric scanning (ImageQuant,
Molecular Dynamics, Inc.). Protein levels were expressed in arbitrary units.

Statistics. Data are presented as mean 土 SEM. All data comparisons fbr length-passive
tension determinations were done by a one way analysis of variance followed by a
Student Newman-Keuls test. All other comparisons were done by unpaired studenfs t-

test. P< 0.05 was considered as statistically significant in all analyses.
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Modification of previous methods for In Vivo Application of Antisense

Oligonucleotides

In the in vitro preparations utilized for examination of the effects of antisense inhibition
of kinesin protein synthesis, untreated control tissues were found to contain a
significantly lowered kinesin concentration as compared to fresh tissues. In order to

study the effects of inhibition of kinesin synthesis on tissues which contained a full

complement of kinesin protein levels, it became important to utilize an in vivo method.

The method most commonly used fbr in vivo transfer of oligonucleotides called for the
incorporation of the oligonucleotides into a detergent-like pluronic gel. The
characteristics of pluronic gels make them unsuited for examination of smooth muscle

functions because even short-term application of these compound causes massive

increases in plasma cholesterol levels. This is significant to the study of smooth muscle

contraction because elevated plasma cholesterol levels cause potentiation of the
contraction and consequently; an inert delivery media was needed. Knox gelatin was

used fbr application of antisense oligonucleotides since it did not raise plasma cholesterol
levels or have significant effects on the contraction.

Preparation of Packing Vehicle. For studies using pluronic gel, the pluronic gel F127

powder (BASF) was mixed with cold water at a concentration of 25%. Preparation of the

gelatin vehicle was accomplished by first adding a small amount of room temperature
distilled deionized water (ddH2O) (100 ul) to 0.04 g of gelatin, since this swells the
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gelatin and improves its solubility. After several minutes, 300 ul boiling ddH2O were
added and the mixture gently agitated until the gelatin was completely dissolved. When
the gelatin was completely in solution, 250 ul room temperature ddH2O was added and

the mixture was put on ice briefly to cool.

Incorporation of Compounds into Packing Vehicle. For oligonucleotide incorporation
into pluronic gel, 8 umoles sense or antisense oligonucleotide was added to the mixture

before it began to gel. For addition of oligonucleotides to the gelatin vehicle, 8 uMol
sense or antisense oligonucleotide was first mixed with 50 uL Lipofectin® and incubated

fbr several minutes to allow liposomes to form. This mixture was then added to the

gelatin after it had reached room temperature, but before it had begun to solidify.
Phorbol 12,13 dibutyrate (1 O'6 M) and P-galactosidase containing plasmid (100 ug) were
incorporated in the same manner.

Application of Pluronic Gel or Gelatin Vehicle. The vehicle containing kinesin sense
or antisense oligonucleotides, PDB or plasmid encoding /^-galactosidase was applied to

aortae in situ by a modification of the method of Bennett et al. (1994). Rats were
anesthetized with ketamine:xylazine (21:9 mg/kg). The abdomen was opened, the vehicle
containing the compound to be studied or vehicle alone was packed around the abdominal
aorta, and the preparation was covered with a square of polyvinyl-chloride film prior to
replacement of the intestines. Following this procedure, the rats were allowed free access
to Purina Rat Chow and tap water. After 24 hours, the abdominal aortae were removed
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and prepared for contractility measurements.

Tissue preparation. The evaluation of in vitro contractile response was performed as

described above (Pg. 40) except for that the abdominal aortae were utilized in these
experiments.

Immunoblot Analysis. Determination of the effectiveness of the in vivo application of
kinesin antisense oligonucleotides was performed the same as fbr the determination of
kinesin levels in in vitro studies as described above (Pgs. 44-45)

Statistics. Data were presented as mean 士 SEM. Comparisons were done by unpaired
Student's t-test. P< 0.05 was considered as statistically significant in all analyses.

The Effects of Kinase Inhibitors on Smooth Muscle Contraction

Because there is an established role for many kinases in the generation and maintenance

of active force in smooth muscle, and because many of these kinases exert their effects

either directly or indirectly on the components of the cytoskeleton, a panel of specific

kinase inhibitors were examined to assess their effects on the fast and slow components
of contraction.
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Tissue preparation. The evaluation of in vitro contractile responses was performed as

described above (Pg. 40).

Inhibition of Kinase Activity. The effect of inhibition of enzyme activity of several
kinases reported to be present in smooth muscle was examined by the application of

specific inhibitors to the contractile baths. For most inhibitors, concentrations of 10
percent of IC50(as determined by the manufacturer), 100 percent of IC50 and 1000 percent

IC50 were applied and allowed to remain in the baths 30 minutes prior to contraction with
80 mM potassium. For staurosporine inhibition of PKC, concentrations of 3, 6, and 30

nM were used in the same manner.

Statistics. Data were presented as mean 土 SEM. Comparisons were done by unpaired
Student's t-test. P< 0.05 was considered as statistically significant in all analyses.

Evaluation of the Interactions Between the Cytoskeleton and Protein
Kinase C

Based on the results from previous experiments, PKC was selected for further study. It is

well established that PKC must be translocated from its resting position in the cytosol to

cellular membranes to be fully enzymatically activated. Because the microtubules are
responsible fbr the transport of many cellular components, and because the inhibition of
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slow phase contraction produced by microtubular disruption is similar to that caused by
inhibition of PKC activity, a possible role fbr the microtubules in the translocation of
PKC was examined. Initially, cell fractionation and Western blot analysis were utilized

for this purpose. However, because the resolving power of this type of analysis is limited

to discerning between only a particulate and a cytosolic fraction, a more powerful
technique was essential. The use of confocal microscopic techniques allowed for
visualization of PKC movements in response to phorbol ester stimulation, and the effects

of cytoskeletal disruption on this process were examined.

Cell Culture. Aortae were aseptically removed from 100 g male rats and the cells were

enzymatically dispersed in a cocktail of collagenase, elastase, DNAse, soybean trypsin
inhibitor and bovine serum albumin (BSA) in Hanks Buffered Saline Solution (HBSS)

containing calcium. Dispersion was carried out in a 37° C shaker bath fbr 60 minutes.
Following dispersion, cells were strained through a fine mesh to filter out residual
connective tissue, and the cells were centrifuged to remove the digesion media. The cell
pellet was then resuspended in serum-free Dulbecco's Modified Eagle Media (DMEM).

This cell suspension was plated into a 25 mm2 tissue culture flask and allowed to incubate
fbr 2 hours to allow cell attachment. After this initial period of attachment, DMEM

containing 10% fetal calf serum was added. Cells were maintained at 37° C in an

atmosphere of 5% CO2 in air. Upon reaching confluence, cells were detached from the
plate with a trypsin/EDTA solution in HBSS and were split into 2 or more flasks

depending upon the number of cells. This procedure was repeated at regular intervals as
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cells reached confluence. Only cells in passage two through six were utilized fbr
experiments.

PKC Translocation. Translocation of protein kinase C was initiated by the addition of
10*6 M phorbol 12,13 dibutyrate (PDB) for 10 minutes to tissues or to cells in culture.
Cultured smooth muscle cells were isolated from rat aorta and utilized in passages 2-6.

To assess their effects on translocation, colchicine (40 ug/ml, 20 minutes) or cytochalasin

B (1 ug/ml, 5 minutes) was added prior to phorbol stimulation. For the combined cold
plus colchicine treatment, tissues or cells were maintained on ice fbr 60 minutes with
colchicine (40 ug/ml) added at 40 minutes. At the end of the cooling interval, the

samples were rewarmed to 37°C and equilibrated fbr an additional 60 minutes before the
addition of PDB.

Immunoblot Analysis. In order to determine PKC levels in the cell soluble and

particulate fractions, fresh aorta or cultured cells were homogenized in lysis buffer (20

mM Tris, pH 7.5; 0.5 mM EDTA; 0.5 mM EGTA; 25 ug/mL aprotinin; 25 ug/mL
leupeptin) at 4°C. Cells were washed once with ice-cold lysis buffer and were then
homogenized by several passages through a 21 -gauge needle. These homogenates were

centrifuged at 100,000g fbr 60 min at 4°C and the supernatant was reserved as the
cytosolic fraction. The pellet was re-solubilized in lysis buffer containing 0.5% Triton X-

100, and the resulting suspension was maintained on ice for 40 minutes. The suspension
was then re-centrifuged at 100,000g fbr 60 min at 4°C, and the supernatant analyzed as
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the particulate or membrane fraction. Protein concentrations were determined by the
BCA®(Pierce) protein assay. Samples of equal protein concentrations were denatured in

sample buffer (50 mM Tris, 10% glycerol, 20 mM DTT) before being subjected to 10%
SDS-PAGE. Proteins were electrically transferred to Hybond® nitrocellulose membrane

(Amersham) and the membrane incubated for 1 hour at room temperature in blocking

solution (5% nonfat dry milk in phosphate buffered saline, pH7.5, containing 0.5%

Tween-20). A 1:2000 dilution of monoclonal anti-PKC a antibody (UBI) was then added
for 1 hour at room temperature. Detection of protein was performed as described above
(Pg. 45).

Microscopy. Rat aortic smooth muscle cells in the second through sixth passage were
grown on glass coverslips until the cells had attached and begun to spread. The cells

were untreated (vehicle) or were exposed to cytochalasin B or colchicine and were then
left in the presence or absence of PDB fbr 30 seconds to 10 minutes. To prepare fdr
staining, the cells were fixed and permeabilized in ice cold acetone fbr one minute. For

immunolocalization of PKC, this was followed by incubation with antibody specific to
PKC-a (UBI) fbr 30 minutes at room temperature followed by washing in PBS, and the

addition of an FITC labeled secondary antibody fbr 30 minutes at room temperature. For
co-localization studies, PKC-a was visualized with a Texas Red labeled secondary

antibody (Molecular Probes) and tubulin by a FITC labeled primary antibody. The
preparations were mounted on a Nikon Diaphot microscope, and confocal microscopy

was performed with a BioRad Model 1024 scanning system using a krypton/argon laser.
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Final micrographic images were built by projecting serial Z-plane image acquisitions and
were analyzed using Lasersharp and Confocal Assistant software (BioRad, CA).

Statistics. Data were presented as mean 土 SEM. Comparisons were done by unpaired

Student's t-test. P< 0.05 was considered as statistically significant in all analyses.
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Ill Results

The Effects of Cytoskeletal Disruption on Smooth Muscle Contractility

With the tissues held at passive tensions of 1 g to 20 g, the relationship between the
preload and the tissue length was nearly linear (Figure 3). Within this range of passive
tension preload, there were marked differences in the fast and slow components of the
active tension response to potassium depolarization of the tissue (Figure 4). The fast

component of active tension development was significantly increased by increasing the
preload from 1 g to 5 g and subsequent increases in the preload from 5 g to 15 g had no

fiirther effect on the magnitude of the fast component. However, increasing the preload

from 15 g to 20 g resulted in an approximate 50% reduction in the fast response as
compared to the peak value obtained at 10 g of passive tension. By comparison, the slow

component of the active tension response showed no effect of increasing the preload up to

10 g. At higher preloads, the slow response fell sharply and was approximately 30% of
the peak value when stretched to 20 g of passive tension.

In order to assess the role of the cytoskeleton on the relationship between passive tension
preload, tissue length, and active tension development, the drugs colchicine and
cytochalasin B were used to selectively inhibit the microtubule and actin-containing

cytoskeletal components, respectively. Colchicine has been demonstrated to cause

disassembly of actively polymerizing microtubules, whereas the cytochalasins bind the
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Length - passive tension relationship of untreated control tissues. Each
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Effect of increasing passive tension on active tension development in
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components. Active tension is presented as percent of 1g reference contraction. Pooled
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same component.
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barbed end of actin and prevent dynamic remodeling of the actin cytoskeleton. The

treatment of tissues with cytochalasin B had no observable effect on the relationship
between passive tension and tissue length (Figure 5). By comparison, the exposure of the

tissues to colchicine at 37°C resulted in a shift of the curve to the right, indicating a slight
increase in the mechanical resistance to stretch in these tissues. Because tissues weights

were identical between groups, these results could not be attributed to differences in the
size of the tissues. Colchicine disruption of the actively polymerizing microtubules
resulted in a shift of the active tension-passive tension preload curve to the left (Figure

6A). The resolution of the active response of colchicine-treated tissues into their fast and
slow components further revealed that this phenomenon was due to a marked

enhancement of the fast response at preloads up to 10 g (Figure 7A), and a reduction in
the slow response at 10 g to 15 g of passive tension preload (Figure 7B). By comparison,

cytochalasin B caused a significant reduction in the active tension response at each tissue
preload studied (Figure 6B), and this effect was due almost exclusively to a reduction of
the slow response (Figure 8).

There appears to be a large population of microtubules that are insensitive to colchicine

but that may be depolymerized by cooling to 0°C for 60 minutes (Tsutsui et al., 1994).
Because colchicine exerts its effects on actively polymerizing microtubules, it was

reasoned that by adding colchicine prior to the rewarming of the tissues and the
subsequent repolymerization of the microtubules, the effect of the dissolution of this

more stable microtubule population on contraction could be observed. The fast
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increasing preload. (A) Disruption of microtubules by colchicine (■) as compared to
control (•). (B) Inhibition of actin polymerization by cytochalasin B (▲) as compared to
control (•). All data are presented as percent of reference contraction at 1 g. Pooled
reference values for colchicine; 2.47 ± 0.12 g, and cytochalasin B: 2.43 土 0.09 g. Each
point represents the average of 8 to 13 tissues. * indicates a significant difference (p<
0.05) from control values at given preload.
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component of the contractile response of tissues that were cooled and rewarmed was
significantly increased; whereas, the slow component of the response was identical to
control tissues which were maintained at 37° C throughout the experiment (Figure 9).

The colchicine-treated tissues that were cooled and rewarmed, however, showed a
significant reduction in the slow component of contraction but no significant effect on the
fast component of active tension development compared to control indicating the
effective reduction of both the fast and slow component compared to cooled and

rewarmed tissues (Figure 9). Cooling and rewarming of the tissues in either the presence
or absence of colchicine did not have a significant effect on the passive tension-tissue

length relationship (Figure 10).

Incubation of aortic rings with antisense oligonucleotides to kinesin heavy chain reduced

the amount of kinesin protein by an average of 35% compared to sense oligonucleotide-

treated tissues, as determined by SDS-PAGE analysis (Figure 11). The reduction of

kinesin heavy chain protein synthesis by the incubation of aortic rings with antisense
oligonucleotide in vitro resulted in the reduction of the contractile response to potassium
by about 35% as compared to control tissues. The inhibition of response was evenly

distributed between the fast and slow components (Figure 12). The results obtained from
tissues exposed to kinesin heavy chain sense and antisense oligonucleotides

situ were

effectively identical to those incubated with the oligonucleotides in organ culture (data

not shown). These results could not be attributed to an effect of the antisense
oligonucleotide on the mechanical properties of the tissue (Figure 13). The tissue length-
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Figure 9
Effects of cold temperature and rewarming in the presence or absence of
colchicine on the fast and slow components of the contractile response to 80mM K+.
Values represent the average of 5 to 9 tissues. Data are presented as percent of reference
(Fast = 0.90 土 0.05g, Slow = 2.29 土 1.23g. An asterisk indicates a significant difference
from control tissues that were not cooled but were maintained at 37°C throughout the
experiment. * indicates a significant difference (p< 0.05) from control tissue.
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Figure 10
Length - passive tension relationship of cooled and rewarmed tissues
treated with colchicine. Colchicine (•), cold-treated control (■), cold-treated+colchicine
(▲). Each point is an average of 7 to 9 tissues.
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Effects of the kinesin antisense (hatched bar) and corresponding sense
control (open bar) oligonucleotides on the fast and slow components of contraction.
Aortic rings were incubated in organ culture with oligonucleotides for 24h prior to
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passive tension preload curve of aortic rings maintained in organ culture fbr 24 hours was
shifted to the right as compared to that of freshly excised rings. However, there were no

significant differences in this length-passive tension relationship of control aortic rings in
culture and those tissues cultured in the presence of oligonucleotides.

In Vivo Application of Kinesin Antisense Oligonucleotides

Effects of Pluronic Gel F127

The application of pluronic gel to the abdominal aorta

produced a dramatic increase in plasma cholesterol levels (Figure 14). These increases in

cholesterol were accompanied by a significant increase in the contractile response of the
tissues, and this increase was confined primarily to the slow phase of contraction (Figure

15). This rise could be inhibited by the addition of PDB to the pluronic gel prior to
application (Figure 15); however, cholesterol levels remained high (Figure 14). The

application of kinesin antisense oligonucleotides in pluronic gel had little to no effect on

the contraction (Figure 15).

Effects of Gelatin

Because of the unphysiological plasma cholesterol levels induced by

the pluronic gel, and because many cellular functions, including smooth muscle

contraction, are affected by high cholesterol, an alternative vehicle for oligonucleotide
delivery was used. A biologically inert gelatin compound was employed as a vehicle fbr

the same compounds previously used with the pluronic gel. To test whether this method
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Figure 14
Effect of in vivo application of pluronic gel Fl 27 on plasma cholesterol
levels. Twenty four hour exposure produced approximately a ten-fold increase over
control levels. Values represent pooled plasma from 3-5 rats.
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Effect of in vivo application of pluronic gel F127 on high potassiumFigure 15
induced contraction of rat aorta. Gel was applied alone or in combination with either 10 °
M phorbol 12,13 dibutyrate or kinesin antisense oligonucleotide (8 pmoles). Results are
expressed as grams of active tension developed and are divided into fast and slow
components of contraction. Bars represent averaged values of 6-12 tissues, * indicates a
significant difference (p< 0.05) from fresh tissue levels.
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could be used to both transport DNA into the cell and also to allow this DNA to be

translated into a protein product, a vector expressing P-galactosidase was added to the
gelatin matrix and applied to the abdominal aorta. After a 24 hour incubation, tissues
showed a significant increase in P-galactosidase protein levels as determined by

colorimetric assay (Figure 16). The application of gelatin alone had no effects on the
plasma cholesterol (data not shown), nor did it affect contraction (Figure 17). The
addition of PDB (IO-6 M)to the gelatin produced reductions in the contraction, although
not as markedly as in the pluronic treated tissues (Figure 17) . The incorporation of

kinesin antisense oligonucleotides produced a significant reduction in the contraction
(Figure 17). The presence of kinesin heavy chain antisense oligonucleotides also

produced a significant reduction in kinesin heavy chain protein levels (35-40%) that was

comparable to the reductions in kinesin levels seen in in vitro studies (data not shown).

The Effects of Kinase Inhibitors on Smooth Muscle Contraction

A prominent role has been established for several kinases in smooth muscle contraction.

These include MLCK, CaMK, PKC and, most recently, MAP kinase (Figure 18). In

order to directly assess the role of these kinases as well as several other kinases which are
implicated in playing a role in contraction, specific inliibitors fbr each kinase were

employed, and their effects on tissue contractility were observed. Protein kinase A
(PKA) is an enzyme found in many cell types, including smooth muscle; however, it has
71
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Figure 16
Effect of in vivo application of knox gelatin on high potassium-induced
contraction of rat aorta. Knox preparation was applied alone or in combination with
either 10'6 M phorbol 12,13 dibutyrate, kinesin antisense oligonucleotide or kinesin sense
oligonucleotide (8 jimoles). Results are expressed as grams of active tension developed
and are divided into fast and slow components of contraction. Bars represent averaged
values of 4-10 tissues. * indicates a significant difference (p< 0.05) from appropriate
control.
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Efficiency of beta-galactosidase vector incorporation into rat aorta when
applied in a Knox gelatin preparation. Results are expressed in arbitrary
spectrophotometric units and represent averaged values of three experiments. * indicates
a significant difference (p< 0.05) from control.
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activation of smooth muscle contraction. MLCK, myosin light chain kinase. MLC,
myosin light chain. CaMKII, calcium-dependent calmodulin kinase. —P indicates a
protein phosphorylation.
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not been shown have an effect on contraction. In our hands, the application of specific

inhibitors to PKA had no effect on contraction (Figure 19). Tyrosine kinases are also

abundant in smooth muscle, and are beginning to be suspected to play role in the
contraction. In our hands, specific suppression of tyrosine kinase activity had no effects

of contraction; however, when the tyrosine kinase inhibitor genistein was used at a

concentration which also inhibited pp60src, the contraction was inhibited (Figure 20).

This reduction was confined to the fast phase of contraction. It is suggested in the
literature that MAP kinase may play a role in smooth muscle contraction. Specific

inhibition of MAP kinase by olomoucine produced a significant reduction in the total
contraction, and this loss was due to a loss of fast phase contraction (Figure 21).

Of the kinases that are well established to be instrumental in producing and in
maintaining smooth muscle contraction, both MLCK and PKC are suspected to facilitate

or enhance smooth muscle contraction while CaMK activity is associated with a
modulation of contraction. Therefore, inhibition of MLCK or PKC would be expected to
decrease the level of active tension developed upon agonist stimulation, and CaMK

suppression would be expected to produce either no change in the strength of contraction

or to facilitate the generation of greater force by removing the repression that CaMK
activity provides. In the case of PKC, the results were comparable to previously reported

data; staurosporine inhibition of kinase activity caused an inhibition of contraction

(Figure 22). Inhibition of MLCK with ML-9 [1-(5- chloronapthalene- 1 - sulfonyl)
homopiperazine HCL] also produced an inhibition of the contraction as would be
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Figure 19
Effect of H-8 ( N - [ 2 - (methylamino) ethyl] - 5 isoquinolinesulfonamide HCL} inhibition of protein kinase A on high potassium-induced
contraction in rat aorta. Values are reported as percent of reference contraction and are
divided into fast and slow components. H-8 was added at concentrations of 37 nM, 370
nM or 3700 nM. Values are averages of 6-8 tissues.
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L-------o--------- inhibition of tyrosine
,
.
、
contraction in rat aorta. Values are reported as percent ofreference
contraction andi are
at concentrations of 2.6x 10'
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---------------’M, 2.6x IO* M or 2.6x 10'5 M. Values are averages of 6-8 tissues. * indicates a
significant difference (p< 0.05) from control.
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Figure 21
Effect of olomoucine inhibition of mitogen activated protein kinase on
high potassium-induced contraction in rat aorta. Values are reported as percent of
reference contraction and are divided into fast and slow components. Olomoucine was
added at concentrations of 1.5 uM, 15 uM or 150 uM. Values are averages of 6-8 tissues.
* indicates a significant difference (p< 0.05) from control.
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Effect of staurosporine inhibition of protein kinase C on high potassiumFigure 22
induced contraction in rat aorta. Values are reported as percent of reference contraction
and are divided into fast and slow components. Staurosporine was added at
concentrations of 3 nM, 6 nM or 30 nM. Values are averages of 6-8 tissues, * indicates a
significant difference (p< 0.05) from control.
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expected, however, it was found that this loss of contractility by the tissue was confined

to the fast phase of contraction at a concentration corresponding to the IC50 (Figure 23).
While this is consistent for a role fbr myosin phosphorylation in this portion of the

contraction, it is commonly held that myosin phosphorylation is responsible for both the
development and the maintenance of slow phase contraction as well. Finally, inhibition

of CaMK with KN-62 (1- [ N, O- bis ( 5- Isoquinolinesulfbnyl)- N - methyl- L - tyrosyl]-

4- phenylpiperazine} produced a loss of contractility in both phases of the contraction
(Figure 24).

Evaluation of the Interactions Between the Cytoskeleton and Protein
KinaseC

Disruption of the Cytoskeleton

In order to assess the effect of selective disruption of

components of the cytoskeleton on PKC translocation, the drugs colchicine and

cytochalasin B were utilized to inhibit polymerization of cellular microtubules and actin
microfilaments, respectively (Figures 25, 26). There appears to be a substantial portion of

microtubules that are quite stable and therefore, insensitive to colchicine (Dentler and
Adams, 1992), but which are depolymerized by cooling to 0°C fbr 60 minutes (Tsutsui et

al., 1993). Consequently, in most of the experiments, tissues and cells were cooled to
0°C with colchicine added just prior to rewarming to prevent repolymerization of the

microtubules. Treatment with colchicine disrupted the filamentous appearance of the
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Effect ofML-9 [1- (5- chloronapthalene- 1- sulfonyl) homopiperazine
Figure 23
HCL] inhibition of myosin light chain kinase on high potassium-induced contraction in
*
rat aorta. Values are reported as percent ofreference
contraction andI are divided into fast
and slow components. ML-9 was added at concentrations of 0.38 nM, 3.8 nM or 38 nM.
Values are averages of 6-8 tissues, * indicates a significant difference (p< 0.05) from
control.
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Figure 24
Effect of KN-62 (1- [ N, O- bis ( 5- Isoquinolinesulfonyl)- N - methyl- L tyrosyl]- 4- phenylpiperazine} inhibition of calcium-dependent protein kinase on high
potassium-induced contraction in rat aorta. Values are reported as percent of reference
contraction and are divided into fast and slow components. KN-62 was added at
concentrations of 90 nM, 900 nM or 9000 nM. Values are averages of 6-8 tissues, *
indicates a significant difference (p< 0.05) from control.
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A

Figure
Confocal micrograph showing normal smooth muscle
Figure 26
actin distribution (a) and lhe disrupiion of this portion of the cytoskeleton
by the addition ofcx tochalasin B (b). a potent inhibitor of aelin
Lin 11 laments are stained by the addition of Cy3 labeled
polymerization. Aelin---phalloidin.
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microtubules as observed by confocal microscopy, producing a punctate pattern of

staining (Figure 25). There was evidence of some residual tubular structure remaining
following colchicine treatment which is consistent with the presence of a colchicine
insensitive population of microtubules (Dentler and Adams, 1992). The combination of

cold treatment and colchicine produced a more extreme disruption of the microtubular

network, however, a small degree of filamentous structure could still be observed in the
cells (data not shown).

Treatment with cytochalasin B to disrupt the actin containing cytoskeleton produced a

marked reduction in the number of actin filaments (Figure 26). However, there was not a

complete dissolution of the actin cytoskeleton. This finding suggests a population of
stable actin filaments that are insensitive to the actions of cytochalasin, which acts only
on actively polymerizing actin. In addition to the apparent loss of F-actin, there was also

a notable change in the shape of the cell. The cell membrane was observed to lose its

smooth appearance and began to develop pronounced projections. This change in cell
shape is presumably due to the depolymerization of cytoskeletal F-actin.

Effect of Disruption of the Cytoskeleton on PKC Translocation To determine the

effects of disruption of different components of the cytoskeleton on PKC translocation,
we first examined the change in the ratio of cytosolic to particulate PKC following

stimulation with PDB. Western blot analysis revealed that disruption of the microtubular

but not the microfilament component of the cytoskeleton significantly reduced the ratio of
85

PKC in the particulate to the soluble fraction of stimulated cells, suggesting the inhibition
of translocation from the cytosol to membrane structure (Figure 27). The decrease in
ratio was greater in cells treated by cooling plus colchicine (〜80%) compared to those

treated with colchicine alone (-60%) (Figure 28). The results show equally clearly that

tissue rewarmed after cooling to 0° C had no impairment of PKC translocation to the

particulate fraction (Figure 28).

Because Western analysis provides only an indirect measure of PKC translocation, the
effect of cytoskeletal disruption on the translocation of PKC-a was studied using laser
confocal microscopic analysis. Prior to stimulation, cells stained fbr PKC-a showed a

diffuse distribution throughout the cytoplasm (Figure 29A). By comparison, the

treatment of control cells with PDB to activate PKC initiated translocation resulting in
intense immunostaining fbr PKC-a at the perinuclear region of the cell by 10 minutes

after the addition of PDB (Figure 29B). Incubation of unstimulated (Figure 29C) and

stimulated (Figure 29D) cells with secondary antibody in the absence of primary antibody
indicated that PKC-a translocation observations were not significantly influenced by non-

specific staining. As seen in Figure 30, dual immunostaining indicated that, prior to
stimulation, PKC-a was diffusely distributed throughout the cytoplasm showing little or
no relationship with microtubular structure. Within 30 seconds following PDB addition,

PKC-a was observed to localize to filamentous strands (Figure 3 IB), reflecting co
localization with microtubules (Figure 31 A). Although some evidence of PKC-a

association with the microtubules remained at 10 minutes after PDB addition, co86
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Figure 27
Bar graph showing the changes in membranous to cytoplasmic ratio of
PKC-a in cultured rat aortic smooth muscle cells after treatment with cytochalasin B
(CB) to inhibit actin polymerization, and colchicine (CH) to disrupt the microtubular
cytoskeleton. FS denotes stimulated control tissues. Data were derived using
densitometric data from Western blots and is presented as mean 土 SEM. Values indicate
the average from 5-7 experiments. * indicates a significant difference (p< 0.05) from
control.
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Figure 28
PKC-a in cultured rat aortic smooth muscle cells after treatment with colchicine only or
with the combination of cold treatment and colchicine to disrupt microtubules. Data were
derived using densitometric data from Western blots and is presented as mean 土 SEM.
Values indicate the average of 4-7 experiments. * indicates a significant difference (p<
0.05) from control.
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D

Coriibcal inicrogiaph showing the translocation of PKC-alpha to the perinuclear
Figui'e 29
region following PDB stimulation, (a) Smootli muscle cell labeled for PKC-alpha prior
to stimulation exliibits a cliffiise cytoplasinic localization for PKC-alpha. (b) Smooth muscle
cell labeled for PKC-alpha 10 minutes after PDB addition, and PKC-alpha translocation to tlie
peiinuclear ureu. PKC is visualized by the addition of ail inilabeled primary antibody
to PKC-alpha( UBI) followed by a FITC labeled anti-mouse IgG secondary antibody.
(c) Smootli nniscle cells incubated with secondary antibody in the absence of primary antibody.
(d) Smootli muscle cells stimulated with PDB and incubated with secondary antibody in
the absence primary antibody. Non-specific inumuiofluorescence is niiiiinial in both cases
and does not show any movement upon PDB stimulation, indicating that tlie PKC staining
and ti-aiislocation noted in (a) and (b) are not due to non-specific binding of the secondary
antibody. Micrographs are representative from images collected in 4-9 individual experiments.
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A

B

Dual immunostaining for the microtubules (a) and
PKC-alpha (b) in unstimulated cells. PKC is \ isualized by Texas Red
labeled secondan antibody and inicrolubules are stained with F1TC labeled
alpha-iubulin antibody. Images were collected in separate channels to
prc\ cnl oxerlap of tluorophores. Micrographs are representalive ironi
images collected in 5 individual experiments.
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A

B

Dual inimunostaining for the inicrotubiilcs (a) and
Figure 31
PKC-alpha (b) in PDB stimulated cells 30 seconds following PDB
addiiion. PKC is visualized by Texas Red labeled sccondarx antibody and
microiubules arc stained with FITC labeled alpha-tubulin antibody. Images
were collected in separate channels to prevent overlap of fluorophores.
Micrographs are representative from images collected in 3 individual
cxpciiinents.
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localization of PKC-a and microtubular structure was largely obscured by PKC-a
translocation and the resulting intense staining of the perinuclear region of the cell

(Figure 32). Treatment with colchicine had no observable effect on the diffuse
distribution of PKC-a in unstimulated cells (Figure 33a). However, treatment with

colchicine caused a dramatic inhibition of PKC-a translocation to the perinuclear
membrane in PDB stimulated cells (Figure 33b). In marked contrast to the effect of

colchicine, treatment with cytochalasin B at concentrations shown to severely reduce

filamentous actin structure within the cell had no significant effect on PKC-a

translocation (Figure 34). The results indicate that PKC-a associates with the
microtubular cytoskeleton and that the directional movement of this isofbrm during
stimulation-induced translocation requires an intact microtubular system.

Tissue Contractile Response

Because PKC inhibition has been reported to specifically

block slow tension development in smooth muscle (Wright and Hum, 1994), we

examined the effect of disruption of the microtubular cytoskeleton on contractile
properties of the rat aortic ring as a physiological measure of PKC activation. The

stimulation of smooth muscle by increasing the concentration of extracellular potassium
induces contraction due to plasma membrane depolarization (Holman, 1958), resulting in
the voItage-dependent activation of calcium channels (Bosca and Moran, 1993) and

influx of calcium into the cell (Briggs, 1962; Urakula and Holland, 1964). The

consequent increase in intracellular calcium then initiates the contractile response. The
contractile response of rat aortic smooth muscle may be divided into two distinct
92

B

Dual ininiunostaining lor the microiubules (a) and
Figure 32
PK( -uipha (b) in PDB slimulated cells 10 minuies following PDB
addiiion. PKC is visualized b\ Texas Red labeled secondary anlibodx and
mic \)iubules arc stained with FITC labeled alpha-lubulin antibod). 1 mages
wcic collected in separate channels to prexenl oxerlap of iluorophores.
Mici oiiraphs are representali\e irom images collected in 5 individual
expci iincnls.
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A

B

Confocal micrograph showing the ellect of colchicine on
PKC-alpha translocation, (a) Colchicine treated smoolh muscle cell labeled
for P Kt'-alpha prior to sliinulalion displays a diffuse cytoplasmic
locali/ation lor PKC-alpha. (b) Colchicine treated smooth muscle cell
labeled ibr PKC-alpha after PDB sliinulalion. movement of PKC-alpha to
the perinuclear region is ellectixel} inhibilecl. Localization of PKC is
\ isuuli/cd b\r the addition of an FITC labeled anli-mouse IgG secondary
antibodx. Micrographs are representative of images collected in 4 separate
experiments.
Figure 33
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A

B

Con local micrograph showing the eHecl of cytochalasin B
Eigurc 34
on PKC'-alpha translocation, (a) C'\ lochalasin B treated smooth muscle
cell labeled for PKC-alpha prior to stimulalion displays a dilluse
c\ loplasmic localization ibr PKC-alpha. (b) Cytochalasin B treated
sniooih muscle cell labeled tbr PKC-alpha after PDB stimulation.
PKC -alpha is marked!} translocated to the perinuclear area. PKC is
st j i ncd b\ the addition of an F1TC labeled anti-mouse IgG secondan
aniibodx. Micrographs are representative of images collected in 4 separate
experiments.

components, an initial rapid increase in tension followed by a prolonged, slow elevation

of tension (Wright and Hum, 1994). The fast component accounts for about 35% of the
total tension developed and is complete within 10 seconds; whereas, the slow component

requires an average of 27 minutes for completion. The fast and slow components have
been shown to exhibit distinctly different physiological and pharmacological properties

(Wright and Hum, 1994) suggesting that different mechanisms regulate these

components. In particular, it has been shown that very low concentrations (8X10-9M) of
the PKC antagonist staurosporine selectively inhibits the slow component of response.

Partial disruption of the microtubules by colchicine did not significantly affect the

contractile response to potassium depolarization (Figure 9). By comparison, the more

extensive depletion of the microtubules by the combined treatment of tissue cooling plus
colchicine significantly decreased tension development with the effect confined

exclusively to the slow component (〜60%). The results are consistent with a direct role
of PKC in slow tension development and the blockade of PKC translocation/activation by

disruption of the microtubular cytoskeleton. However, the alteration of the contractile
response was found to correlate only poorly with the degree of inhibition of translocation;

both colchicine alone and colchicine in combination with cell cooling significantly

attenuated the translocation of PKC-a while only the more severe treatment reduced the
slow component of the contractile response. A possible explanation is that the colchicine

treatment was less effective in tissues than in the cells in culture and that all parts of the
tissue did not receive optimal exposure to the drug. It is also possible that the activation
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of only a portion of the PKC available is sufficient to support slow tension increases and
the more severe disruption of microtubules was required for a threshold effect on

contractile responsiveness.
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IV Discussion

Smooth muscle exhibits a number of unique contractile properties for which the

underlying mechanisms are unknown or only poorly understood. For example, various
types of smooth muscle have the ability to slowly contract and to then maintain a stable

active tension fbr hours in vitro. The contractile response of rat aorta to potassium
describes an initial fast phase in which approximately 35% of total force is developed

within ten seconds (Wright and Hum, 1994) while the remaining 65% of maximal force

is subsequently generated over an interval of up to thirty minutes. It has been
demonstrated that the contractile response of rat aortic rings can be separated into its fast

and slow components on the basis of several physiological and pharmacological criteria.

For example, the slow response shows markedly increased sensitivity to extracellular
Ca2+, temperature, and potassium depolarization compared to the fast component. In
addition, it was shown that cytochalasins, which influence actin polymerization and

inhibit filament elongation, could be utilized to selectively inhibit the slow response,
indicating that this component requires a restructuring of the actin cytoskeleton fbr

effective generation of force. These observations suggest that distinctly different
mechanisms regulate the fast and slow components of the contractile response in aortic
smooth muscle and that remodeling in the actin-containing portion of the cytomatrix is a

key element in producing the slow response.
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The active tension-length curve of smooth muscle is generally similar to that of skeletal

muscle (Herlihy and Murphy, 1973) indicating that force is generated by a sliding
filament mechanism. However, the active tension-length relationship of smooth muscle

is much broader than reported for skeletal muscle (Rudel and Taylor, 1971) with the

capability for contraction at a smaller fraction of Lo — defined as the tissue length which
produces optimal contraction (Herlihy and Murphy, 1973; Speden, I960) and maximal or

near maximal force obtained through a relatively wide range of tissue preload and length.
Furthermore, it has been shown that increasing the passive tension-preload of rat aortic

rings from 1 g to 8 g increased the magnitude of the fast response but did not alter the
slow response (Wright and Hum, 1994). Hence, the broad and relatively shallow active

tension preload curve of this tissue can be explained in terms of the impervious nature of
slow force development to preload and tissue stretch. In light of the selective effect of
cytochalasin on the slow response (Figure 8), it can be surmised that the apparent
detachment of this response from the influence of preload is due to the formation or

rearrangement of a portion of the tension bearing structure associated with the contractile

protein following stimulation of the tissue.

The present results (Figure 8) confirm earlier findings that the application of cytochalasin

prior to tissue stimulation selectively blocks the slow response without changing the
passive tension-length relationship of the tissue (Figure 5 ). Cytochalasins do not

influence force development in skeletal (Alberts et al., 1983) or cardiac (Tsutsui et al.,
1993) muscle and are ineffective in the disassembly of the highly structured and stable
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actin/myosin assemblies found in sliding filament arrangements (Croop and Holtzer,

1975). In addition, recent work has ruled out the possibility that cytochalasin causes its
effects in smooth muscle via alterations in calcium influx, intracellular calcium,
membrane potential or myosin light chain phosphorylation which are unchanged with
cytochalasin treatment (Obara and Yabu, 1994). Hence, the effects of cytochalasin on

smooth muscle appear to be mediated entirely through its inhibitory effect on actin
polymerization. Because the fast component of the contractile response of aortic smooth

muscle is not altered by cytochalasin (Figure 8), it may be concluded that this component

involves a stable actin filament structure. Because cytochalasins can be utilized to block
the slow response if applied prior to tissue stimulation (Figure 8) but have little effect on

tension if they are introduced into the bath after tension development has plateaued

(Wright and Hum, 1994). These results suggest that actin polymerization and filament
elongation are critical elements of slow force development and that the actin filaments

created are stable against cytochalasin attack upon completion of the slow response.

In order to explain the broad tissue length-active tension curve and the relative isolation

of the slow component of the contractile response from the effect of increasing tissue
length, a restructuring of the cytoskeleton can be proposed that would provide a

mechanism for the internal adjustment of tension on the contractile apparatus. This
theoretical system for tension adjustment occurs in conjunction with the contractile

proteins, not as a stand-alone structure. Myosin-associated actin is found in rosettes or
cross-linked bundles (Cooke and Fay, 1972) that provide fbr multiple filament
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attachments extending to anchorage points at the membrane or at other sites in the cell.

Stretch results in a less than optimal association between the intercalating actin and

myosin filaments and adjustment to allow the actin filament to move into a more optimal

position for interaction with myosin could occur by three possible mechanisms. Actin
filaments could disengage and reattach to other anchorage sites, slippage at the anchorage

site could lessen tension on the actin filament, or polymerization of actin filaments from
the bundle to new anchorage sites with disassembly of filaments under tension could
realign the interacting actin-myosin complex. Based on the dramatic effect of

cytochalasin inhibition of actin polymerization on the contractile response, new filament

formation is probably the most likely mechanism by which the cytoskeleton is
restructured for adjustment of tension and regulation of the spatial relationship of actin

and myosin filaments.

The linking of the concept of an adjustable cytoskeletal tension-bearing element with the

assumption that there is only partial or asynchronous activation of the cell complement of

contractile protein during the interval following agonist stimulation in which [Ca2"]j
declines or cycles, could further explain slow tension increase and the long-term

maintenance of tension in smooth muscle. In the interval immediately following agonist
stimulation and the elevation of [Ca2"]j5 the full complement of contractile protein would

contract resulting in a relatively abrupt development of force comparable to the fast
component of response. Subsequently, during the interval of declining [Ca2+]j and

decreased myosin light chain phosphorylation (Zhang and Moreland, 1994), only a
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portion of the contractile protein would be activated at any given time, effectively

resulting in asynchronous activation/inactivation of the contractile protein. An
accompanying remodeling of tension-bearing actin cables would serve to lock the system
at the existing tension and preserve increases in force generated by the activated

complement of contractile protein. Hence, the system would act as a ratcheting

mechanism with the rate of increase in force primarily determined by the percentage of
contractile protein activated at any given time. The plateau would correspond to the
interval of very low level activation of the contractile protein with tension maintained by

the restructured tension-bearing components of the system.

In addition to indicating a role for actin filaments, the results suggest that cellular
microtubules could contribute to the contractile properties of smooth muscle. The

treatment of aortic rings with colchicine at 37°C enhanced the fast response, shifted the

active tension-passive tension preload curve of the slow response to the left, and caused
the passive tension preload-length curve to shift to the right. The last observation

indicates that the system of microtubules contributes to the mechanical properties of the
tissue and that partial disassembly of this system results in increased resistance to stretch

by the passive tension preload. Because of the high flexural rigidity and expected
inextensibility of microtubules (Gittes et aL, 1993), the microtubular system would not be

expected to convey increased elasticity to the tissue. Hence, it may be reasonable to
speculate that the microtubules provide a support structure for elements directly

responsible for the lowered resistance to stretch in control tissues compared to colchicine-
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treated tissues. It has been shown that the structural arrangement of intermediate

filaments is altered following microtubule disassembly by colchicine alkaloids in
fibroblasts (Virtanen et al., 1980) suggesting that this treatment has secondary effects in

the cytoskeleton.

The effects of colchicine at 37°C on active tension were quite different in the fast and

slow components of the response. The mechanism of enhancement of the fast response
by microtubule dissolution (Figure 9) is not clear, but may be similar to that operating in

pressure hypertrophied myocardial cells exhibiting increased contractile responsiveness
following treatment with colchicine or lowered temperature to cause microtubule
disassembly (Tsutsui, et al., 1994). These studies indicated that the effect of colchicine to

enhance contraction was specific to the microtubules and suggested that the microtubule
component of the cytoskeleton acted to create a viscous load that would impede

sarcomere shortening. By comparison, disruption of microtubules attenuated the slow
response at preloads above 5 grams, effectively shifting the active tension-length curve to
the left fbr this component. This strongly suggests that the microtubules play a role in
determining the mechanical properties of tissue specifically with regard to slow force

development.

Microtubules play a central role in numerous fbrce-generating processes by acting as the
structural element for the movement of cellular motor proteins. These microtubule-

associated motors are presently grouped into the kinesin, dynein, and dynamin
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superfamilies. Kinesin is a heterotetramer consisting of two heavy chains and two light
chains (Bloom et al., 1988; Kuznetsov et al., 1988). The heavy chains contain the highly

conserved motor domain and additional sites suspected of regulating motor activity and
mediating interactions between the light chains and cargo carried by the motor (Walker

and Sheetz, 1993). A number of kinesin-like proteins have been reported that are similar

in the motor domain but are variable in other regions suggesting these proteins will differ
in the type of cargo carried (Vale and Goldstein, 1990). Moreover, recent evidence
suggests that kinesins may be able to interact with more than one microtubule and

kinesin- like proteins may interact with actin filaments (Hoyt, 1994). At present, the
kinesins are implicated in a number of cell functions and this can be expected to greatly
expand as more kinesin-related proteins are discovered and the full range of their

interactions with the cytoskeleton and other components of the cell are understood.

It has been reported (Matthies et al., 1993) that extensively purified bovine brain kinesin

showed several forms of heavy and light chains. Using SDS-PAGE analysis the group

demonstrated at least three fonns of kinesin heavy chain with molecular masses between

120 and 130 kDa and a high molecular weight species above 200 kDa which they
suggested could be an aggregate containing kinesin heavy chain. To our knowledge, the

kinesin profile in SDS-PAGE analysis of rat aortic smooth muscle has not been
previously examined. Our results show a species of kinesin at approximately 116 kDa in
fresh aortic tissue. However, in cultured tissues we see proteolytic fragments of kinesin
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heavy chain indicating a high rate of degradation in vitro. Also, on occasion a high
molecular weight species was noted that appears similar to the observation of Matthies et

al. (1993) in neural cells. The proteolytic fragments appear as a triplet band at 85 kDa, a
single band at 70 kDa, and a triplet band at 48 kDa. These bands are consistent with

kinesin fragments seen in Xenopus muscle as reported by Sigma Immunochemicals.
Antisense oligonucleotides have been previously used to successfully block kinesin

synthesis in neural cells in culture (Matthies et al., 1993) and in situ (Amartunga et al.,
1993) with estimated suppression of kinesin heavy chain protein levels in excess of 95%

within 24 hours after addition of antisense oligonucleotides (Matthies et al., 1993).
Previous work with in situ application of oligonucleotides has commonly utilized

pluronic gels as vehicles fbr oligonucleotide delivery. Pluronic gels are detergent-like
compounds that have the characteristic of rapidly raising both plasma cholesterol and
triglyceride levels when introduced in whole animal studies (Wout et al., 1992). Because

elevated plasma cholesterol levels have been shown to cause increases in smooth muscle
contractile response (Yokoyama and Henry, 1979), we developed a modified method fbr
delivery of oligonucleotide. We found that a Knox gelatin preparation could be used to
selectively place kinesin antisense oligonucleotides around the abdominal aorta and, in

our hands, the application of antisense oligonucleotides to aortic rings in vitro or to the
abdominal aorta in situ produced a reduction of kinesin protein levels by 35%. The
difference in efficiency of antisense suppression in this work and that previously reported
may be due to the inherent differences between oligonucleotide delivery in the intact

tissues and the dispersed cell preparation, or it may be due to differences in the tissue
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types. In the present study, employing antisense oligonucleotide against the kinesin

heavy chain to the abdominal aorta in situ, and to the thoracic aorta in organ culture
produced identical results, a 35% to 40% reduction in the contractile response, compared

to sense oligonucleotide-treated tissues (Figure 12). The results suggest that the kinesins
could play a role in the development of force by aortic smooth muscle, either through a
stmctural support function or through a role in the transduction process.

Several of the kinases reported to be involved in transducing agonist stimulation into
smooth muscle contraction were examined with respect to their effects on the fast and
slow portions of the smooth muscle contraction. MLCK is considered to be the initiating

kinase of smooth muscle contraction. We found that specific inhibition of MLCK
activity caused a significant, but not complete, inhibition of contraction. In addition, this

inhibition was primarily in the fast component of contraction with little or no effect on
the slow phase. While this finding corroborates evidence suggesting that the fast phase of

contraction may be regulated and function similarly to striated muscle contractile
mechanisms, it suggests that development of slow tension is not solely regulated by

MLCK activity. Inhibition of calcium dependent calmodulin kinase (CaMKII) also
produced unexpected results. Based on what is known about the role of this kinase in the

smooth muscle contraction, we expected that its inhibition would either produce no effect

or would potentiate the contraction. We found that inhibition of CaMKII produced an

inhibition of tension generation and that this was in both the fast and slow portions of the

contraction. This finding would indicate that there may be a secondary role for CaMKII
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in the mechanism of smooth muscle contraction. This could possibly be through
differential effects of CaMKII on MLCK phosphorylation, phosphorylation of
caidesmon, or via an effect on mitogen activated protein (MAP) kinase activity.
Although MAP kinase has also been suggested to play a role in smooth muscle

contraction, the mechanism for its function is not known. Inhibition of MAP kinase
produced an inhibition of fast phase contraction, possibly indicating a role for MAP

kinase in the regulation of MLCK activity or actin:myosin cycling.

The role of PKC in smooth muscle contraction has been extensively examined, and it

appears that PKC is involved in the generation and maintenance of contraction. This
involvement seems to be primarily in the slow phase contraction, although the current
work also shows some effect on fast phase contraction as well. One of the unique
features of PKC is that it must be translocated within the cell in order to be fully

activated. Prior to activation, PKC is found diffusely throughout the cytoplasm.
Following stimulation, it translocates to cellular membranes where it becomes fully

activated.

The mechanism of PKC translocation and the basis fbr isofbrm targeting and substrate

specificity is only recently becoming clear (Haller et al., 1990). The work of Bosca and
Moran (1993) indicated the importance of calcium and phorbol ester, a synthetic form of
diacylglycerol, in the initiation of translocation through an unfolding of the PKC

molecule. This conformational change uncovers hydrophobic tryptophan residues that
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are concealed within the hydrophilic a-helical structure of the unactivated kinase. They

concluded that the hydrophobicity and the increased affinity fbr membrane phospholipid
of the activated molecule would prompt movement from the cytosol to membrane

localization sites. Because PKC isofbrms are translocated to different sites, however, this
mechanism did not adequately explain the specificity of isofbrm translocation. The case
fbr selective isofbnii binding as the mechanism underlying differential localization of

isofbrms following activation was greatly strengthened by the discovery of receptors fbr
activated C kinase (RACKs) (Mochly-Rosen et al., 1991). This family of receptors is
found in the membrane and contains binding sites that are specific fbr individual

activated isofbrms (Mochly-Rosen, 1995). Hence, the presence of these proteins would

allow only a specific isofbrm of activated PKC to bind to a particular subcellular
compartment once the PKC molecule came in proximity to its complimentary RACK.
The intermediate step of this process, the means by which PKC is physically moved from
the cytosol to the membrane sites is generally thought to be due to simple diffusion.

However, in view of the potential diffusional barriers presented by the cellular

cytoarchitecture, it may be reasonable to suspect that movement by diffusion would be
poorly controlled and incomplete.

The present results indicate that following the activation of PKC-a by addition of PDB,

this isofbrm was seen to extensively and rapidly co-localize with microtubules during

translocation to the perinuclear membrane (Figure 31). Use of colchicine or colchicine

plus cold to disrupt the microtubular system within the cell dramatically reduces the
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relocation of PKC-a from the cytosol to the particulate fraction (Figures 27,28) and

prevents the translocation of the molecule to the perinuclear membrane (Figure 33).
These findings corroborate contractile data indicating that the microtubules play an

important role in smooth muscle contraction and that this is due to their function in the
transport of PKC during the translocation process. Because inhibition of kinesin protein

synthesis through the application of antisense oligonucleotides resulted in a

coiTesponding reduction in the contractile response of rat aortic smooth muscle, and
because of the effects of microtubular disruption on PKC translocation, it may be
reasonable to speculate that the importance of kinesin to the smooth muscle contraction

could be due to kinesin-mediated transport of PKC. Translocation of PKC via this type

of highly structured system could result in a more controlled and efficient PKC

movement to specific subcellular sites as compared to random diffusion. Kinesin-like

proteins, while maintaining a high degree of homology within their motor domains,
display variability within the domains involved in cargo binding. This opens the

possibility fbr individual motor protein types to be involved in the selective transport of
different cargo molecules to specific subcellular locations. This type of regulation could
be important under conditions of physiological cell stimulation where differential

transport could act as a means of compartmentalizing the activity of several
simultaneously acting isofbrms.

In studies reported here, only translocation of the alpha isofbrm of PKC was examined.

This isofbrm is present in high concentrations in cultured rat aortic smooth muscle cells
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and the characteristics of its translocation to the perinuclear area have previously been
described in passaged cells (Haller et al., 1990). However, of the five PKC isofbrms

identified in smooth muscle (Kahlil and Morgan, 1996), only evidence for the
involvement of PKC-g in contraction has been obtained. Upon agonist stimulation, this

isofbirn translocates before or during the interval of contraction (Kahlil and Morgan,

1993) and has been further shown to induce a calcium-independent contraction in
penneabilized ferret aortic cells (Horowitz et al., 1996). Because both the translocation
of PKC-a and the contractile response of vascular smooth muscle were inhibited by

disruption of the microtubules, these results suggest that microtubular transport could
affect more than one PKC isofbrm.
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V Summary

In summary, disruption of cellular microtubules or inhibition of actively polymerizing

actin selectively inhibits the slow component of contraction. This suggests that both of

these components of the cytoskeleton contribute to slow tension development either
through a structural role or through involvement in the transduction process.

Additionally, disruption of the microtubular system prevents the translocation of PKC-a
to the perinuclear membrane. This, coupled with the observation that the blockade of
microtubule associated motor protein synthesis attenuates the contractile response,

suggests that the microtubules play an important role in smooth muscle contraction by
functioning as a directional transport system fbr the translocation of PKC. These results
further indicate that both the non-actin:myosin cytoskeleton and the array of kinases

present in smooth muscle play a vital role in the generation of active contractile force.
Because both of these components are potentially important in producing and regulating

smooth muscle contraction, further investigation into their actions and interactions is

necessary and studies to this end should prove to be greatly beneficial to our
understanding of the mechanics and regulation of smooth muscle contraction.
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